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Background: Major Depressive Disorder (MDD) is a clinically heterogeneous psychiatric 
disorder with a polygenic architecture. Genome-wide association studies have identified a 
number of risk-associated variants across the genome, and growing evidence of NETRIN1 
pathway involvement. Stratifying disease risk by genetic variation within the NETRIN1 
pathway may provide important routes for identification of disease mechanisms by focusing 
on a specific process excluding heterogeneous risk-associated variation in other pathways. 
Here, we sought to investigate whether MDD polygenic risk scores derived from the 
NETRIN1 signaling pathway (NETRIN1-PRS) and the whole genome excluding NETRIN1 
pathway genes (genomic-PRS) were associated with white matter microstructure.  
Methods: We used two diffusion tensor imaging measures, fractional anisotropy (FA) and 
mean diffusivity (MD), in the most up-to-date UK Biobank neuroimaging data release (FA: N 
= 6,401; MD: N = 6,390).  
Results: We found significantly lower FA in the superior longitudinal fasciculus (β = -0.035, 
pcorrected = 0.029) and significantly higher MD in a global measure of thalamic radiations (β = 
0.029, pcorrected = 0.021), as well as higher MD in the superior (β = 0.034, pcorrected = 0.039) and 
inferior (β = 0.029, pcorrected = 0.043) longitudinal fasciculus and in the anterior (β = 0.025, 
pcorrected = 0.046) and superior (β = 0.027, pcorrected = 0.043) thalamic radiation associated with 
NETRIN1-PRS. Genomic-PRS was also associated with lower FA and higher MD in several 
tracts.  
Conclusions: Our findings indicate that variation in the NETRIN1 signaling pathway may 

















Major Depressive Disorder (MDD) is a common and frequently disabling psychiatric 
disorder and a leading cause of disability worldwide (1). MDD is known to result from a 
complex combination of environmental and genetic factors (2; 3), with a moderate 
heritability of approximately 37% (4; 5; 6).  
Genome-wide association studies (GWAS) suggest that at least part of MDD’s 
heritability is due to the cumulative effect of alleles of small effect size (7; 8) and have 
identified a number of risk-associated genetic variants across the genome (6; 7; 9; 10; 11). 
Significant findings for GWAS analyses can also be annotated to specific biological 
pathways, revealing underlying cellular and molecular mechanisms.  
Following several GWAS, the Psychiatric Genomics Consortium (PGC) have identified 
an aggregation of variants in several specific biological pathways (12; 13). In MDD, Zeng et 
al. (2017) (14) combined pathway and regional heritability analysis in two independent 
samples and reported that the NETRIN1 signaling pathway was involved in the genetic 
aetiology of MDD. Moreover, polygenic risk scores (PRS) calculated for this pathway alone 
more accurately predicted MDD in one of the cohorts compared to PRS calculated for the 
whole genome. Genetic variation within the NETRIN1 signaling pathway may therefore 
capture more aetiologically circumscribed liability for MDD that is less susceptible to 
heterogeneous influences from other biological pathways. 
Animal studies have previously indicated that NETRIN1, by binding to and activating 
NETRIN1 receptors such as ‘Deleted in Colorectal Cancer’ (DCC), plays an important role in 
commissural and cortical axon guidance (15). More recently, DCC was identified as playing 















leads to successful axon growth during central nervous system development (16). GWAS of 
other traits related to MDD have also shown an aggregation of variants in the NETRIN1 
pathway (17; 18).  
Previous studies have attempted to investigate psychiatric disorders by examining 
relevant quantitative traits such as brain structure or function (19). Differences in white 
matter (WM) integrity as measured by diffusion tensor imaging (DTI) have been found 
between MDD patients and healthy participants in numerous studies, although findings have 
been widely inconsistent (20; 21; 22). For example, Shen et al. (2017) (20) found 
significantly lower global white matter integrity in association fibres and thalamic radiations, 
as measured by fractional anisotropy (FA), in MDD patients compared to healthy individuals. 
More specifically, they also found lower FA in the left superior longitudinal fasciculus, 
superior thalamic radiations and forceps major tracts in MDD patients. Lower WM integrity 
as measured by FA has also been found in adolescents with MDD as compared to age-
matched healthy individuals (21; 22). 
It has previously been shown that the NETRIN1 signaling pathway is associated with 
MDD and white matter microstructure (14). Therefore, in the current study, we sought to 
investigate the association between MDD risk-associated variants in the NETRIN1 signaling 
pathway and white matter integrity. We first created polygenic risk scores for pathway SNPs 
(NETRIN1-PRS) and SNPs excluded from the pathway (genomic-PRS). We then tested their 
association with WM integrity as measured by FA and mean diffusivity (MD). We used the 
most up-to-date genetic and imaging data available (N after exclusion steps: FA = 6,401; MD 















significantly associated with WM integrity, after adjustment for genomic-PRS, indicating a 
































Methods and Materials 
UK Biobank  
The UKB study consists of 502,617 community-dwelling individuals who were recruited 
between 2006 and 2010 in the United Kingdom 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=200). UKB received ethical approval from 
the Research Ethics Committee (reference: 11/NW/0382). This study has been approved by 
the UKB Access Committee (Project #4844). Written informed consent was obtained from all 
participants. 
Study population 
In the most recent UKB imaging data release, 8,839 individuals (N female = 4,639; N 
male = 4,200; mean age: 62.54 +/- 7.42 years; age range: 45.17 – 79.33) completed DTI 
assessment, and a quality check by UKB. In addition to this, for the current study, individuals 
were excluded if they participated in studies from the PGC MDD GWAS (24) or Generation 
Scotland (Scottish Family Health Study), or if they happened to be related, as the PGC MDD 
GWAS dataset was used in order to calculate PRS. Moreover, individuals whose FA and MD 
values were greater than three standard deviations above/below the mean were not included 
in the study (Supplementary Material, tables S4 and S5). This resulted in 6,401 individuals 
with FA values (N female = 3,334; N male = 3,067; mean age: 62.60 +/- 7.37; age range: 
45.92 – 78.42; Ncontrol: 3,736; Ncase: 2,512) and 6,390 individuals with MD values (N female = 
3,327; N male = 3,063; mean age: 62.58 +/- 7.36; age range: 45.92 – 78.42; Ncontrol: 3,729; 
Ncase: 2,508), excluding 19 and 30 individuals with FA and MD values from a total of 6,420, 
respectively. Details of data exclusion as well as participant information for the full dataset 

















Genic SNPs found in the NETRIN1 signaling pathway as taken from Zeng et al.’s (2017) 
study (14) (N genes = 43; gene list is presented in the Supplementary Material, table S3) and 
genic SNPs excluded from the pathway were annotated using the program ANNOVAR. 
ANNOVAR is a biostatistical tool used to annotate genetic variants to functional genomic 
regions (23). In the current study, we performed a gene-based annotation for SNPs used in 
the largest available GWAS of MDD (N=461,134, of which 130,664 were MDD cases), 
carried out by the Psychiatric Genomics Consortium (24), which includes summary statistics 
from the personal genetics company 23andMe, Inc. (10). We defined gene boundaries as an 
extended region of 20 kb from transcription start sites and transcription end sites. After SNPs 
were annotated to genes, they were further mapped to the NETRIN1 signalling pathway. All 
protein-coding genes within this file were annotated in reference to hg 19. Intergenic SNPs 
were not included in the annotated files. The resulting output file included: function of each 
SNP, gene name, chromosome number, start position, end position, reference and alternative 
alleles, odds ratio, standard error and p-value for each variant.  
Following functional annotation, a file containing the 43 gene names included in the 
NETRIN1 signaling pathway was used as an input in order to extract gene-based SNPs 
located in the pathway. For the genomic-PRS, all gene-based SNPs excluding those 
implicated in the NETRIN1 signaling pathway were extracted. The two files were then used 
as input for creation of PRS. 
Genotyping and PRS profiling 
A total of 488,363 UKB blood samples (N female = 264,857; N male = 223,506; 
http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=22001), were genotyped using two different 















(http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=149600) and UK Biobank Axiom array (N 
= 438,417) (http://biobank.ctsu.ox.ac.uk/crystal/refer.cgi?id=149601). Details of genotyping 
and quality control are described in more detail by Hagenaars et al. (2016) (25) and Bycroft 
et al. (2017) (26).  
Using the largest available GWAS of MDD, PRS for each individual were computed 
using PRSice (27), at five p-value thresholds (0.01, 0.05, 0.1, 0.5, 1) by adding the number of 
risk alleles and weighting them by the strength of association with MDD. PRS were created 
both from SNPs annotated to the NETRIN1 signalling pathway and from SNPs from the rest 
of the genome, thus resulting in separate PRS lists. PRS were created both with and without 
clump-based pruning of SNPs in linkage disequilibrium (r2 = 0.25, 250km window). The 
primary analysis reported in this manuscript concerns unpruned SNPs, owing to the potential 
of causal variants within the NETRIN1 pathway to be in LD with other variants, and uses 
SNPs which met a significance level of p = 0.5, in line with previous studies (28; 29). 
Secondary analyses with other PRS p-value thresholds, as well as with LD pruned SNPs, are 
presented in the Supplementary Material (Tables S6 – S21). 
MRI acquisition  
In the present study, imaging-derived phenotypes (IDPs) produced by UKB were used. 
MRI acquisition and pre-processing procedures for FA and MD values of white matter tracts 
were performed by UKB using standardised protocols 
(https://biobank.ctsu.ox.ac.uk/crystal/docs/brain_mri.pdf). Briefly, images were collected on 
a single Siemens Skyra 3.0 T scanner with a standard Siemens 32-channel head coil and were 
pre-processed using FSL packages; parcellation of white matter tracts was conducted using 
AutoPtx (30).  















matter tracts, of which 12 are bilateral and three are unilateral. The white matter tracts were 
also categorised into three separate subsets, as follows: association fibres: inferior fronto-
occipital fasciculus, uncinate fasciculus, cingulum bundle (gyrus and parahippocampal), 
superior and inferior longitudinal fasciculus; thalamic radiation fibres: anterior, superior and 
posterior thalamic radiations; projection fibres: forceps major and minor, corticospinal tract, 
acoustic radiation, medial lemniscus and middle cerebellar peduncle. Global measures of FA 
and MD are referred to as general factors of FA and MD (gFA and gMD, respectively). 
Exclusion criteria comprised removal of scans with severe normalisation problems by 
UKB. Moreover, individuals whose FA and MD values were higher than three standard 
deviations from the sample mean were also excluded. Results for the full dataset with outliers 
included are also presented in the Supplementary Material (tables S1 and S2). Lastly, due to 
the fact that the position of the head and radio-frequency coil in the scanner may affect data 
quality as well as IDPs, three scanner brain position variables which may be used as 
confounding variables in subsequent analyses were generated by UKB: lateral brain position 
– X (http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=25756), transverse brain position –Y 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=25757) and longitudinal brain position – Z 
(http://biobank.ctsu.ox.ac.uk/crystal/field.cgi?id=25758). The three variables were included 
as covariates in the statistical analysis described below.  
Statistical methods 
All analyses were conducted using R (version 3.2.3) in a Linux environment. In order to 
test the association between the NETRIN1 signaling pathway- and genomic pathway-derived 
unpruned PRS lists, we used repeated measures linear mixed-effects models (function “lme” 
in package “nlme”) for 12 bilateral brain regions, correcting for hemisphere, with age, age2, 















array set as covariates. For unilateral tracts, global measures of FA and MD, and tract 
categories, we used a general linear model (function “lm”), using the same covariates as 
above, and without hemisphere included as a separate term in the model. All models included 
both the genomic-PRS and the NETRIN1-PRS as predictor variables. 
First, we tested the association between unpruned PRS (both NETRIN1-PRS and 
genomic-PRS) and global white matter integrity. We applied principal component analysis 
(PCA) on the 27 white matter tracts (12 tracts in both the right and left hemisphere and three 
unilateral tracts) in order to extract a latent measure. Scores of the first unrotated component 
of FA and MD (variance explained = 37.52% for FA and 38.83% for MD) were extracted and 
set as the dependent variable in a general linear model in order to test association with both 
NETRIN1-PRS and genomic-PRS. 
We then examined the three categories of white matter tracts by applying PCA on the 
regions involved in each, as a substantial proportion of white matter microstructural 
properties shows substantial commonality across these pathways (31). Scores of the first 
unrotated component of FA and MD were similarly extracted and set as dependent variables 
in general linear modelling, as above. Variance explained for each white matter tract subset 
was as follows: association fibres: 45.36% (FA), 50.76% (MD); thalamic radiations: 60.85% 
(FA), 73.40% (MD); projection fibres: 35.54% (FA), 29.28% (MD).  
Lastly, we tested the association between PRS (both NETRIN1-PRS and genomic-PRS) 
and each individual white matter tract (N = 15). We used a repeated-effect linear model for 
the 12 bilateral tracts and a random-effect general linear model for the three unilateral tracts.   
False discovery rate correction was applied separately for the 15 individual tracts and for 

















In order to establish that the effect of the NETRIN1 pathway-derived PRS on WM 
integrity as measured by FA and MD was not due to chance, a circular genomic permutation 
was applied to the pathway SNP genotypes (32). This was done by placing all SNPs in the 
whole genome (excluding those in the NETRIN1 pathway) in a circular genome, according to 
their location. We then circularly permuted 1000 SNP lists with the same set size as the 
NETRIN1 pathway. We then created 1000 PRS lists which were then fitted in linear mixed-
effects and general linear models, depending on the white matter tract tested, and their 
association with five white matter tracts and one tract category, found to be significantly 





























Results presented below are significant specifically to each pathway. White matter tracts 
showing a significant association with both the NETRIN1-PRS and the genomic-PRS 
pathways are described in the supplementary materials (pgs. 27-28). Results for all individual 
white matter tracts, tract categories and global measures can be found in tables 1-4 and 
figures 1-4.  
The effect of unpruned NETRIN1-PRS & genomic-PRS on measures of white matter 
integrity – FA (N = 6,401) 
Global measures 
We first tested the effect of NETRIN1-PRS and genomic-PRS on global FA (gFA). 
Lower gFA was significantly associated with higher genomic-PRS (β = -0.033, pcorrected = 
0.011) only.  
Tract categories 
We then tested the association between NETRIN1-PRS and Genomic-PRS and three 
subsets of white matter tracts (association fibres, thalamic radiations and projection fibres). 
Significantly lower FA values in projection fibres were found for genomic-PRS (β = -0.028, 
pcorrected = 0.020) only.  
Individual white matter tracts 
Lastly, we investigated the effect of NETRIN1-PRS and genomic-PRS on WM integrity 
in 15 individual white matter tracts. NETRIN1-PRS, but not genomic-PRS, was associated 
















In the genomic-PRS, we found significantly lower FA in the forceps major (β = -0.031, 
pcorrected = 0.043), forceps minor (β = -0.031, pcorrected = 0.043) and uncinate fasciculus (β = -
0.031, pcorrected = 0.043). None of these tracts showed significant associations with NETRIN1-
PRS. 
The effect of unpruned NETRIN1-PRS & genomic-PRS on measures of white matter 
integrity – MD (N = 6,390) 
Tract categories 
MD values for association fibres (β = 0.041, pcorrected = 0.001) and projection fibres (β = 
0.028, pcorrected = 0.023) were found to be significantly higher for genomic-PRS, but not 
NETRIN1-PRS. MD values for thalamic radiations were found to be significantly higher in 
the NETRIN1-PRS (β = 0.029, pcorrected = 0.021), whereas there was no significant association 
with genomic-PRS. 
Individual white matter tracts 
Within the 15 individual white matter tracts, we found numerous areas significantly 
associated with both the NETRIN1-PRS and genomic-PRS. With regards to NETRIN1-PRS, 
MD values were significantly higher in the inferior longitudinal fasciculus (β = 0.029, 
pcorrected = 0.043), superior longitudinal fasciculus (β = 0.034, pcorrected = 0.039), and in the 
anterior (β = 0.025, pcorrected = 0.046) and superior (β = 0.027, pcorrected = 0.043) thalamic 
radiations. All of these significant associations were specific for NETRIN1-PRS. 
In the genomic-PRS, we found significantly higher MD values in the cingulate gyrus (β = 
0.035, pcorrected = 0.013) and parahippocampal (β = 0.032, pcorrected = 0.014) part of cingulum 
















NETRIN1-PRS, but not genomic-PRS, were found to be individually significantly 
associated with white matter microstructure in the following white matter tracts: superior 
longitudinal fasciculus as measured by lower FA; superior and inferior longitudinal 
fasciculus and anterior and superior thalamic radiations, as well as thalamic radiations tract 
category, as measured by higher MD. Therefore, we additionally performed a circular 
genomic permutation analysis and found that the variance explained by NETRIN1-PRS in 




























In the present study, we aimed to investigate whether PRS calculated from the NETRIN1 
signalling pathway are significantly and specifically associated with WM integrity while 
simultaneously modelling genomic-PRS in more than 6,000 individuals. We found significant 
differences in white matter integrity in both NETRIN1-PRS and genomic-PRS, for both FA 
and MD values. Regarding FA values, for NETRIN1-PRS, but not for genomic-PRS, a 
significant association was observed in the superior longitudinal fasciculus. NETRIN1-PRS 
alone were significantly associated with higher generalised thalamic radiations as measured 
by MD, as well as higher MD in the superior and inferior longitudinal fasciculus, and the 
anterior and superior thalamic radiations. Genomic-PRS were also significantly associated 
with FA and MD values in several tracts. 
One of the main findings in our paper was both a reduction of FA and an increase of MD 
in the SLF in relation to NETRIN1-PRS. The SLF, a tract in association fibres, connects the 
frontal, temporal, parietal and occipital lobes, and has been shown to be highly involved in 
MDD (38; 39). FA reductions in the SLF have also been found in previous studies combining 
genetic and neuroimaging techniques (35), further indicating that the tract might be an 
important biomarker of MDD. In addition to this finding, we also found an increase in MD 
values in the ILF, a tract connecting the temporal and occipital lobes. Key areas in these two 
lobes include the amygdala and hippocampus, which are known to be implicated in emotion 
processing, a process which is disrupted in MDD (40). Previous studies have found disrupted 
white matter integrity in this tract in association with MDD using FA, indicating that it may 
play an important role in the pathophysiology of MDD (35). 
We also found an MD increase in the thalamic radiations tract category. Thalamic 















various cognitive processes, such as attention and wakefulness (34). Thalamocortical axons 
play an important role during development, as their projection from the dorsal thalamus (DT) 
transmit sensory information to the neocortex (33). Thalamic radiations have previously been 
linked to MDD in numerous studies. For instance, a decrease in FA was found in the TR 
subset in a large UKB sample comparing 335 MDD patients with 754 healthy individuals 
(20). This tract subset was also found to be significantly associated with higher PRS, 
indicating that there is a link between the sets of tracts and a potential genetic predisposition 
to MDD (35).  
NETRIN1, and its receptor DCC, one of the genes in the NETRIN1-pathway, have been 
previously implicated in thalamic axonal growth. NETRIN1 promotes growth of 
thalamocortical axons by binding to and activating DCC, which is expressed in the DT. 
Moreover, NETRIN1 has been shown to enhance axonal growth in explants of the DT, as 
well as providing guidance from the DT to the cortex (33). It has also been found that 
serotonin, which is highly implicated in MDD, modulates the effect of NETRIN1 on 
embryonic thalamocortical axons (33; 34; 36). The active involvement of NETRIN1 in 
thalamocortical axonal growth, therefore, may explain our findings, and further confirms that 
there is a potential link between a biological pathway and specific neurobiological markers in 
MDD. 
Several other tracts also showed a significant association of FA (individually in forceps 
major and minor and uncinate fasciculus, and in global measures of FA and projection fibres) 
and MD (individually in cingulate part of the cingulum, parahippocampal part of cingulum 
and uncinate fasciculus, and in global measures of association and projection fibres) with 
genomic-PRS, most of which have also been previously associated with MDD.  (20, 35). This 















and disruptions in white matter integrity, also for variants that lie outside the NETRIN1-DCC 
pathway. As such, these findings suggest that both PRS lists affect integrity across the white 
matter tracts, each with localized, pronounced effect in specific tracts. 
The current study has several strengths and a few potential limitations. First of all, it is the 
largest combined genetic and neuroimaging study investigating the effect of PRS derived 
from a specific biological pathway on white matter integrity, to our knowledge. Moreover, 
our analysis consisted of a population-based sample of ambulant individuals recruited to 
UKB. Our findings might therefore be robust and generalizable to other samples within a 
certain age range, although studies such as UKB are not immune to biases associated with 
study participation, such as collider bias (37). 
In addition to the large sample, the fact that NETRIN1-PRS are derived from only 43 
genes, comprising approximately 0.215% of the genes in the whole genome (N = ~ 20,000) 
suggests that MDD risk associated variation exerts a disproportionate influence on white 
matter microstructure. Our findings are also further supported by permutation analysis. The 
association between the NETRIN1 pathway and white matter integrity is therefore likely to 
reflect the importance of a specific pathway in the pathophysiology of MDD. 
The NETRIN1 signaling pathway has previously been found to be implicated in MDD 
(14). In the current study, we were able to find specific neurobiological structural 
connectivity markers associated with this biological pathway. To our knowledge, the current 
study is the first one to note an association between PRS derived specifically from the 
NETRIN1 signaling pathway and several white matter tracts in a large genetic and 
neuroimaging dataset. This indicates that these brain structures may be involved in the 
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Table 1. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on individual 
white matter tracts (FA values). Statistically significant p-values after false discovery rate 
correction for each pathway individually are shown in bold. R2 = estimate of variance 
explained by each pathway in %. 
Table 2. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on global FA 
and 3 white matter tract categories. Statistically significant p-values after false discovery rate 
correction for each pathway individually are shown in bold. R2 = estimate of variance 
explained by each pathway in %. 
Table 3. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on individual 
white matter tracts (MD values). Statistically significant p-values after false discovery rate 
correction for each pathway individually are shown in bold. R2 = estimate of variance 
explained by each pathway in %. 
Table 4. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on global MD 
and 3 white matter tract subsets. Statistically significant p-values after false discovery rate 
correction for each pathway individually are shown in bold. R2 = estimate of variance 
explained by each pathway in %. 
Table 5. Permutation results for NETRIN1-PRS at PRS threshold 0.5 on 5 significant white 
matter tracts and one significant tract category. 
Figures 1a & 1b. The effect of NETRIN1-PRS & genomic-PRS on FA values of white 
matter tracts. The x-axis indicates the standardised effect size of each pathway's PRS and the 
y-axis indicates the white matter tracts. The legend indicates the tract category belonging to 















Figure 2. The effect of NETRIN1-PRS & genomic-PRS on FA values of tract categories and 
global FA. The x-axis indicates the standardised effect size of each pathway's PRS and the y-
axis indicates the tract categories. The error bar represents standard deviation of mean. 
Figures 3a & 3b. The effect of NETRIN1-PRS & genomic-PRS on MD values of white 
matter tracts. The x-axis indicates the standardised effect size of each pathway's PRS and the 
y-axis indicates the white matter tracts. The legend indicates the tract category belonging to 
each white matter tract. The error bar represents standard deviation of mean. 
Figure 4. The effect of NETRIN1-PRS & genomic-PRS on MD values of tract categories 
and global MD. The x-axis indicates the standardised effect size of each pathway's PRS and 
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part of cingulum -0.025 0.011 
-
2.323 0.020 0.152 0.062 -0.019 0.011 
-
1.817 0.069 0.115 0.038 
Parahippocampal 
part of cingulum -0.008 0.011 
-
0.780 0.435 0.544 0.007 -0.020 0.011 
-






1.997 0.046 0.172 0.053 -0.028 0.012 
-






2.029 0.043 0.172 0.054 -0.024 0.012 
-






3.093 0.002 0.030 0.128 -0.023 0.012 
-
1.988 0.047 0.115 0.053 
Uncinate 
fasciculus -0.019 0.011 
-
1.747 0.081 0.202 0.102 -0.032 0.011 
-

















1.900 0.057 0.172 0.048 -0.015 0.011 
-






1.267 0.205 0.308 0.020 -0.022 0.011 
-






0.493 0.622 0.718 0.003 -0.015 0.012 
-











radiation 0.003 0.011 0.306 0.759 0.814 0.001 -0.013 0.011 
-
1.207 0.228 0.244 0.016 
Corticospinal 
tract 0.002 0.011 0.173 0.863 0.863 0.000 -0.018 0.011 
-
1.632 0.103 0.154 0.034 
Medial 
lemniscus -0.009 0.010 
-
0.842 0.400 0.544 0.008 -0.003 0.010 
-




1.301 0.193 0.308 0.024 -0.032 0.012 
-




1.496 0.135 0.262 0.032 -0.032 0.012 
-






1.476 0.140 0.262 0.032 -0.019 0.012 
-
1.536 0.125 0.170 0.035 
Table 1. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on individual white 
matter tracts (FA values). Statistically significant p-values after false discovery rate correction for 












































-0.026 0.012 -2.197 0.028 0.056 0.068 -0.033 0.012 
-
2.769 0.006 0.011 0.109 
Association 
fibres -0.033 0.012 -2.762 0.006 0.023 0.107 -0.034 0.012 
-
2.836 0.005 0.011 0.113 
Thalamic 
radiations -0.018 0.012 -1.482 0.138 0.185 0.032 -0.022 0.012 
-
1.855 0.064 0.064 0.050 
Projection 
fibres -0.011 0.012 -0.904 0.366 0.366 0.012 -0.029 0.012 
-
2.415 0.016 0.021 0.083 
Table 2. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on global FA and 3 
white matter tract categories. Statistically significant p-values after false discovery rate correction 
for each pathway individually are shown in bold. R2 = estimate of variance explained by each 







































































part of cingulum 
0.020 0.011 1.877 0.061 0.130 0.040 0.035 0.011 3.317 0.001 0.014 0.124 
Parahippocampal 
















0.034 0.011 3.009 0.003 0.039 0.116 0.024 0.011 2.133 0.033 0.071 0.058 
Uncinate 
fasciculus 



































0.004 0.010 0.375 0.708 0.772 0.002 0.019 0.011 1.853 0.064 0.087 0.038 
Corticospinal 
tract 
0.016 0.011 1.399 0.162 0.221 0.025 0.022 0.011 1.921 0.055 0.082 0.047 
Medial 
lemniscus 
0.004 0.011 0.357 0.721 0.772 0.001 0.004 0.011 0.396 0.692 0.741 0.002 
Forceps major 0.018 0.012 1.495 0.135 0.203 -0.026 0.028 0.012 2.362 0.018 0.055 0.019 




0.013 0.012 1.058 0.290 0.363 0.016 0.010 0.012 0.852 0.394 0.455 0.010 
Table 3. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on individual white 
matter tracts (MD values). Statistically significant p-values after false discovery rate correction for 















































gMD 0.028 0.011 2.417 0.016 0.031 0.076 0.034 0.011 2.924 0.003 0.007 0.111 
Association 
fibres 
0.022 0.012 1.897 0.058 0.077 0.048 0.042 0.012 3.591 0.000 0.001 0.172 
Thalamic 
radiations 
0.030 0.011 2.785 0.005 0.021 0.089 0.013 0.011 1.232 0.218 0.218 0.017 
Projection 
fibres 
0.021 0.012 1.766 0.077 0.077 0.045 0.029 0.012 2.380 0.017 0.023 0.081 
Table 4. The effect of NETRIN1-PRS & genomic-PRS at PRS threshold 0.5 on global MD and 3 
white matter tract subsets. Statistically significant p-values after false discovery rate correction for 


































White matter tract 








permutation p value 
Superior longitudinal fasciculus (FA) -0.035 -3.093 0.004 
Superior longitudinal fasciculus (MD) 0.034 3.008 0.004 
Inferior longitudinal fasciculus (MD) 0.029 2.624 0.014 
Anterior thalamic radiations (MD) 0.025 2.419 0.023 
Superior thalamic radiations (MD) 0.027 2.757 0.007 
Thalamic radiations (MD) 0.029 2.785 0.008 
Table 5. Permutation results for NETRIN1-PRS at PRS threshold 0.5 on 5 significant 
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Association of Whole-genome and NETRIN1 Signaling Pathway-derived 
Polygenic Risk Scores for Major Depressive Disorder and White Matter 





· Demographic data concerning complete dataset of individuals with DTI values 
· Descriptive statistics of imaging phenotype 
· NETRIN1 signalling pathway gene list 
· Demographic data and FA descriptive statistics of individuals excluded from the study  
(N = 19) 
· Demographic data and MD descriptive statistics of individuals excluded from the study 
(N = 30) 
· Statistical analysis of FA and MD values containing: 
1. Unpruned NETRIN1- and genomic-PRS with outliers excluded (6,401 for FA and 
6,390 for MD) at all 5 thresholds (0.01, 0.05, 0.1, 0.5, 1) and full sample (6,420) at 
threshold 0.5 
2. Pruned NETRIN1- and Genomic-PRS with outliers excluded (6,401 for FA and 6,390 
for MD) at all 5 thresholds (0.01, 0.05, 0.1, 0.5, 1) and full sample (6,420) at 
threshold 0.5 
· White matter tracts significantly associated with both NETRIN1-PRS and genomic-PRS. 
1. Fractional anisotropy 
2. Mean diffusivity 
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Supplementary tables 
· Table S1. Descriptive statistics of FA values (mean and standard deviation). The full 
dataset contains 6,420 individuals, while the outliers-excluded dataset contains 6,401 
individuals.  
 
· Table S2. Descriptive statistics of MD values (mean and standard deviation). The full 
dataset contains 6,420 individuals, while the outliers-excluded dataset contains 6,390 
individuals. 
 
· Table S3. Gene list and brief gene description included in the NETRIN1 signalling 
pathway, composed of 43 genes. 
 
· Table S4. Descriptive statistics of FA values (mean and standard deviation) for 
individuals excluded from the study (N = 19).  
 
· Table S5. Descriptive statistics of MD values (mean and standard deviation) for 
individuals excluded from the study (N = 30). 
 
· Table S6. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on individual white matter tracts (FA) (N = 6,401). 
 
· Table S7. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on tract categories (FA) (N = 6,401). 
 
· Table S8. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (FA) (N = 6,420). 
 
· Table S9. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (FA) (N = 6,420). 
 
· Table S10. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on individual white matter tracts (MD) (N = 6,390). 
 
· Table S11. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on tract categories (MD) (N = 6,390). 
 
· Table S12. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (MD) (N = 6,420). 
 
· Table S13. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (MD) (N = 6,420). 
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0.1, 0.5 and 1 on individual white matter tracts (FA) (N = 6,401). 
 
· Table S15. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on tract categories (FA) (N = 6,401). 
 
· Table S16. The effect of pruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (FA) (N = 6,420). 
 
· Table S17. The effect of pruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (FA) (N = 6,420). 
 
· Table S18. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on individual white matter tracts (MD) (N = 6,390). 
 
· Table S19. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on tract categories (MD) (N = 6,390). 
 
· Table S20. The effect of pruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (MD) (N = 6,420). 
 
· Table S21. The effect of pruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
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Table S1. Descriptive statistics of FA values (mean and standard deviation). The full dataset 
contains 6,420 individuals, while the outliers-excluded dataset contains 6,401 individuals.  
 
Demographic data concerning complete dataset of individuals with DTI values 
Complete dataset (N = 6,420): N female = 3,345; N male = 3,075; mean age: 62.62 +/- 7.37 
years; age range: 45.92 – 78.42 
 
Descriptive statistics of imaging phenotype 
Fractional Anisotropy   
 Full dataset (N = 6,420) Outliers excluded dataset (N = 6,401) 
White matter tract Mean SD Mean SD 
Cingulate gyrus part of cingulum 
(left) 
0.535 0.035 0.535 0.033 
Cingulate gyrus part of cingulum 
(right) 
0.497 0.034 0.498 0.033 
Parahippocampal part of cingulum 
(left) 
0.314 0.029 0.314 0.028 
Parahippocampal part of cingulum 
(right) 
0.313 0.030 0.313 0.030 
Inferior fronto-occipital fasciculus 
(left) 
0.475 0.024 0.476 0.022 
Inferior fronto-occipital fasciculus 
(right) 
0.465 0.021 0.465 0.020 
Inferior longitudinal fasciculus (left) 0.460 0.021 0.460 0.019 
Inferior longitudinal fasciculus (right) 0.451 0.020 0.451 0.018 
Superior longitudinal fasciculus (left) 0.440 0.022 0.440 0.020 
Superior longitudinal fasciculus 
(right) 
0.423 0.021 0.424 0.019 
Uncinate fasciculus (left) 0.388 0.024 0.388 0.235 
Uncinate fasciculus (right) 0.390 0.021 0.390 0.020 
Anterior thalamic radiation (left) 0.399 0.019 0.399 0.017 
Anterior thalamic radiation (right) 0.392 0.019 0.392 0.017 
Posterior thalamic radiation (left) 0.458 0.022 0.458 0.020 
Posterior thalamic radiation (right) 0.455 0.022 0.456 0.020 
Superior thalamic radiation (left) 0.422 0.019 0.423 0.018 
Superior thalamic radiation (right) 0.422 0.020 0.422 0.018 
Acoustic radiation (left) 0.419 0.023 0.420 0.021 
Acoustic radiation (right) 0.411 0.022 0.412 0.020 
Corticospinal tract (left) 0.545 0.024 0.545 0.022 
Corticospinal tract (right) 0.539 0.025 0.539 0.022 
Medial lemniscus (left) 0.419 0.024 0.419 0.023 
Medial lemniscus (right) 0.422 0.025 0.422 0.024 
Forceps major 0.580 0.029 0.580 0.027 
Forceps minor 0.465 0.022 0.465 0.020 
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Table S2. Descriptive statistics of MD values (mean and standard deviation). The full dataset 
contains 6,420 individuals, while the outliers-excluded dataset contains 6,390 individuals. 
 
Mean Diffusivity   
 Full dataset (N = 6,420) Outliers excluded dataset (N = 6,390) 
White matter tract Mean SD Mean SD 
Cingulate gyrus part of cingulum 
(left) 
0.0007 0.00003 0.0007 0.00002 
Cingulate gyrus part of cingulum 
(right) 
0.0007 0.00003 0.0007 0.00002 
Parahippocampal part of cingulum 
(left) 
0.0008 0.00006 0.0008 0.00005 
Parahippocampal part of cingulum 
(right) 
0.0008 0.00006 0.0008 0.00005 
Inferior fronto-occipital fasciculus 
(left) 
0.0008 0.00003 0.0008 0.00003 
Inferior fronto-occipital fasciculus 
(right) 
0.0008 0.00003 0.0008 0.00003 
Inferior longitudinal fasciculus (left) 0.0008 0.00003 0.0008 0.00003 
Inferior longitudinal fasciculus (right) 0.0008 0.00003 0.0008 0.00003 
Superior longitudinal fasciculus (left) 0.0007 0.00003 0.0007 0.00003 
Superior longitudinal fasciculus 
(right) 
0.0007 0.00003 0.0007 0.00003 
Uncinate fasciculus (left) 0.0008 0.00004 0.0008 0.00003 
Uncinate fasciculus (right) 0.0008 0.00003 0.0008 0.00003 
Anterior thalamic radiation (left) 0.0007 0.00003 0.0007 0.00003 
Anterior thalamic radiation (right) 0.0007 0.00003 0.0007 0.00003 
Posterior thalamic radiation (left) 0.0008 0.00004 0.0008 0.00004 
Posterior thalamic radiation (right) 0.0008 0.00004 0.0008 0.00004 
Superior thalamic radiation (left) 0.0007 0.00003 0.0007 0.00002 
Superior thalamic radiation (right) 0.0007 0.00003 0.0007 0.00002 
Acoustic radiation (left) 0.0007 0.00004 0.0007 0.00003 
Acoustic radiation (right) 0.0007 0.00004 0.0007 0.00003 
Corticospinal tract (left) 0.0007 0.00002 0.0007 0.00002 
Corticospinal tract (right) 0.0007 0.00002 0.0007 0.00002 
Medial lemniscus (left) 0.0009 0.00004 0.0009 0.00003 
Medial lemniscus (right) 0.0009 0.00004 0.0009 0.00003 
Forceps major 0.0009 0.00005 0.0009 0.00005 
Forceps minor 0.0008 0.00003 0.0008 0.00003 
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Table S3. Gene list and brief gene description included in the NETRIN1 signalling pathway, 
composed of 43 genes. 
 
NETRIN1 signalling pathway gene list 
Gene name Description 
UNC5D unc-5 homolog D (C. elegans) 
HFE2 hemochromatosis type 2 (juvenile) 
DCC deleted in colorectal carcinoma 
DOCK1 dedicator of cytokinesis 1 
UNC5B unc-5 homolog B (C. elegans) 
ABLIM3 actin binding LIM protein family, member 3 
FYN FYN oncogene related to SRC, FGR, YES 
RGMB RGM domain family, member B 
ABLIM1 actin binding LIM protein 1 
MYO10 myosin X 
NCK1 NCK adaptor protein 1 
NEO1 neogenin 1 
PITPNA phosphatidylinositol transfer protein, alpha 
PLCG1 phospholipase C, gamma 1 
PRKCQ protein kinase C, theta 
RGMA RGM domain family, member A 
TRPC7 transient receptor potential cation channel 
PTK2 PTK2 protein tyrosine kinase 2 
RAC1 ras-related C3 botulinum toxin substrate 1 percursor 
NTN4 netrin 4 
ROBO1 roundabout, axon guidance receptor, homolog 1 
SIAH1 seven in absentia homolog 1 (Drosophila) 
SIAH2 seven in absentia homolog 2 (Drosophila) 
SLIT1 slit homolog 1 (Drosophila) 
SLIT3 slit homolog 3 (Drosophila) 
SRC v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene 
TRIO triple functional domain (PTPRF interacting) 
TRPC3 transient receptor potential cation channel 
TRPC4 transient receptor potential cation channel 
TRPC5 transient receptor potential cation channel 







UNC5C unc-5 homolog C (C. elegans) 
WASL Wiskott-Aldrich syndrome-like 
UNC5A unc-5 homolog A (C. elegans) 
SLIT2 slit homolog 2 (Drosophila) 
NTN1 netrin 1 
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Table S4. Descriptive statistics of FA values (mean and standard deviation) for individuals 
excluded from the study (N = 19).  
 
Demographic data and FA descriptive statistics of individuals excluded from the study 
(N = 19) 
N female = 11; N male = 8; mean age: 69.26 +/- 4.53 years; age range: 58.92 – 77.42 
Fractional Anisotropy  
 Outlier dataset (N = 19) 
White matter tract Mean SD 
Cingulate gyrus part of cingulum (left) 0.407 0.149 
Cingulate gyrus part of cingulum (right) 0.388 0.144 
Parahippocampal part of cingulum (left) 0.246 0.091 
Parahippocampal part of cingulum (right) 0.254 0.095 
Inferior fronto-occipital fasciculus (left) 0.354 0.127 
Inferior fronto-occipital fasciculus (right) 0.354 0.127 
Inferior longitudinal fasciculus (left) 0.348 0.124 
Inferior longitudinal fasciculus (right) 0.338 0.122 
Superior longitudinal fasciculus (left) 0.325 0.117 
Superior longitudinal fasciculus (right) 0.309 0.112 
Uncinate fasciculus (left) 0.296 0.106 
Uncinate fasciculus (right) 0.301 0.107 
Anterior thalamic radiation (left) 0.306 0.110 
Anterior thalamic radiation (right) 0.306 0.109 
Posterior thalamic radiation (left) 0.358 0.127 
Posterior thalamic radiation (right) 0.350 0.126 
Superior thalamic radiation (left) 0.335 0.119 
Superior thalamic radiation (right) 0.336 0.120 
Acoustic radiation (left) 0.324 0.116 
Acoustic radiation (right) 0.320 0.116 
Corticospinal tract (left) 0.436 0.156 
Corticospinal tract (right) 0.431 0.155 
Medial lemniscus (left) 0.353 0.127 
Medial lemniscus (right) 0.353 0.130 
Forceps major 0.460 0.166 
Forceps minor 0.346 0.125 
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Table S5. Descriptive statistics of MD values (mean and standard deviation) for individuals 
excluded from the study (N = 30). 
 
Demographic data and MD descriptive statistics of individuals excluded from the study 
(N = 30) 
N female = 18; N male = 12; mean age: 70.29 +/- 4.66 years; age range: 58.92 – 77.42 
Mean Diffusivity  
 Outlier dataset (N = 30) 
White matter tract Mean SD 
Cingulate gyrus part of cingulum (left) 0.0007 0.0002 
Cingulate gyrus part of cingulum (right) 0.0007 0.0002 
Parahippocampal part of cingulum (left) 0.0009 0.0002 
Parahippocampal part of cingulum (right) 0.0009 0.0002 
Inferior fronto-occipital fasciculus (left) 0.0008 0.0002 
Inferior fronto-occipital fasciculus (right) 0.0008 0.0002 
Inferior longitudinal fasciculus (left) 0.0008 0.0002 
Inferior longitudinal fasciculus (right) 0.0008 0.0002 
Superior longitudinal fasciculus (left) 0.0008 0.0002 
Superior longitudinal fasciculus (right) 0.0008 0.0002 
Uncinate fasciculus (left) 0.0008 0.0002 
Uncinate fasciculus (right) 0.0008 0.0002 
Anterior thalamic radiation (left) 0.0008 0.0002 
Anterior thalamic radiation (right) 0.0008 0.0002 
Posterior thalamic radiation (left) 0.0009 0.0002 
Posterior thalamic radiation (right) 0.0009 0.0002 
Superior thalamic radiation (left) 0.0007 0.0002 
Superior thalamic radiation (right) 0.0007 0.0002 
Acoustic radiation (left) 0.0008 0.0002 
Acoustic radiation (right) 0.0008 0.0002 
Corticospinal tract (left) 0.0007 0.0002 
Corticospinal tract (right) 0.0007 0.0002 
Medial lemniscus (left) 0.0008 0.0002 
Medial lemniscus (right) 0.0008 0.0002 
Forceps major 0.0009 0.0002 
Forceps minor 0.0008 0.0002 
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Table S6. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on individual white matter tracts (FA) (N = 6,401). 
 
Statistical analysis of FA and MD values containing: 
Unpruned NETRIN1- and genomic-PRS with outliers included (6,420) and outliers excluded 
(6,401 for FA and 6,390 for MD) at all 5 thresholds (0.01, 0.05, 0.1, 0.5, 1) 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 acoustic_radiation -0.002 0.011 -0.166 0.868 
NETRIN1 anterior_thalamic_radiation -0.021 0.011 -1.833 0.067 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.013 0.011 -1.255 0.209 
NETRIN1 
parahippocampal_part_of_cingulum -0.006 0.011 -0.526 0.599 
NETRIN1 corticospinal_tract -0.019 0.011 -1.701 0.089 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.019 0.012 -1.647 0.100 
NETRIN1 
inferior_longitudinal_fasciculus -0.021 0.012 -1.813 0.070 
NETRIN1 medial_lemniscus -0.008 0.010 -0.735 0.462 
NETRIN1 
posterior_thalamic_radiation -0.011 0.011 -0.981 0.326 
NETRIN1 
superior_longitudinal_fasciculus -0.026 0.012 -2.254 0.024 
NETRIN1 
superior_thalamic_radiation -0.015 0.012 -1.251 0.211 
NETRIN1 uncinate_fasciculus -0.018 0.011 -1.680 0.093 
NETRIN1 bl.FA.wm.forceps_major -0.017 0.012 -1.409 0.159 
NETRIN1 bl.FA.wm.forceps_minor -0.011 0.012 -0.934 0.351 
NETRIN1 
bl.FA.wm.middle_cerebellar_peduncle -0.029 0.012 -2.333 0.020 
Genomic acoustic_radiation -0.011 0.011 -1.033 0.301 
Genomic anterior_thalamic_radiation -0.015 0.012 -1.315 0.188 
Genomic 
cingulate_gyrus_part_of_cingulum -0.016 0.011 -1.528 0.127 
Genomic 
parahippocampal_part_of_cingulum -0.019 0.011 -1.779 0.075 
Genomic corticospinal_tract -0.008 0.011 -0.666 0.505 
Genomic 
inferior_fronto_occipital_fasciculus -0.023 0.012 -2.008 0.045 
Genomic 
inferior_longitudinal_fasciculus -0.023 0.012 -1.959 0.050 
Genomic medial_lemniscus 0.003 0.010 0.306 0.760 
Genomic posterior_thalamic_radiation -0.021 0.011 -1.873 0.061 
Genomic 
superior_longitudinal_fasciculus -0.026 0.012 -2.244 0.025 
Genomic superior_thalamic_radiation -0.010 0.012 -0.867 0.386 
Genomic uncinate_fasciculus -0.028 0.011 -2.545 0.011 
Genomic bl.FA.wm.forceps_major -0.037 0.012 -3.042 0.002 
Genomic bl.FA.wm.forceps_minor -0.031 0.012 -2.600 0.009 
Genomic 
bl.FA.wm.middle_cerebellar_peduncle -0.009 0.012 -0.730 0.465 
     
PGRS THRESHOLD: 0.05     
NETRIN1 acoustic_radiation 0.009 0.011 0.819 0.413 
NETRIN1 anterior_thalamic_radiation -0.015 0.011 -1.282 0.200 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.011 0.011 -1.065 0.287 
NETRIN1 
parahippocampal_part_of_cingulum -0.013 0.011 -1.197 0.232 
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 Value Std. Error t-value p-value 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.005 0.011 -0.473 0.636 
NETRIN1 
inferior_longitudinal_fasciculus -0.010 0.011 -0.841 0.400 
NETRIN1 medial_lemniscus -0.005 0.010 -0.456 0.649 
NETRIN1 
posterior_thalamic_radiation -0.002 0.011 -0.205 0.838 
NETRIN1 
superior_longitudinal_fasciculus -0.015 0.012 -1.265 0.206 
NETRIN1 
superior_thalamic_radiation -0.001 0.012 -0.049 0.961 
NETRIN1 uncinate_fasciculus -0.009 0.011 -0.876 0.381 
NETRIN1 bl.FA.wm.forceps_major -0.008 0.012 -0.644 0.520 
NETRIN1 bl.FA.wm.forceps_minor -0.005 0.012 -0.397 0.691 
NETRIN1 
bl.FA.wm.middle_cerebellar_peduncle -0.018 0.012 -1.461 0.144 
Genomic acoustic_radiation -0.012 0.011 -1.151 0.250 
Genomic anterior_thalamic_radiation -0.017 0.011 -1.459 0.145 
Genomic 
cingulate_gyrus_part_of_cingulum -0.019 0.011 -1.739 0.082 
Genomic 
parahippocampal_part_of_cingulum -0.019 0.011 -1.771 0.077 
Genomic corticospinal_tract -0.012 0.011 -1.037 0.300 
Genomic 
inferior_fronto_occipital_fasciculus -0.026 0.012 -2.292 0.022 
Genomic 
inferior_longitudinal_fasciculus -0.026 0.012 -2.252 0.024 
Genomic medial_lemniscus 0.000 0.010 0.037 0.970 
Genomic posterior_thalamic_radiation -0.026 0.011 -2.357 0.018 
Genomic 
superior_longitudinal_fasciculus -0.029 0.012 -2.500 0.012 
Genomic superior_thalamic_radiation -0.015 0.012 -1.296 0.195 
Genomic uncinate_fasciculus -0.030 0.011 -2.725 0.006 
Genomic bl.FA.wm.forceps_major -0.037 0.012 -3.083 0.002 
Genomic bl.FA.wm.forceps_minor -0.034 0.012 -2.834 0.005 
Genomic 
bl.FA.wm.middle_cerebellar_peduncle -0.012 0.012 -0.983 0.326 
     
PGRS THRESHOLD: 0.1     
NETRIN1 acoustic_radiation 0.005 0.011 0.443 0.658 
NETRIN1 anterior_thalamic_radiation -0.018 0.011 -1.580 0.114 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.016 0.011 -1.528 0.127 
NETRIN1 
parahippocampal_part_of_cingulum -0.006 0.011 -0.580 0.562 
NETRIN1 corticospinal_tract -0.004 0.011 -0.314 0.753 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.013 0.011 -1.090 0.276 
NETRIN1 
inferior_longitudinal_fasciculus -0.013 0.012 -1.091 0.275 
NETRIN1 medial_lemniscus -0.016 0.010 -1.569 0.117 
NETRIN1 
posterior_thalamic_radiation -0.005 0.011 -0.481 0.631 
NETRIN1 
superior_longitudinal_fasciculus -0.024 0.012 -2.065 0.039 
NETRIN1 
superior_thalamic_radiation -0.010 0.012 -0.827 0.408 
NETRIN1 uncinate_fasciculus -0.008 0.011 -0.756 0.450 
NETRIN1 bl.FA.wm.forceps_major -0.014 0.012 -1.145 0.252 
NETRIN1 bl.FA.wm.forceps_minor -0.011 0.012 -0.934 0.350 
NETRIN1 
bl.FA.wm.middle_cerebellar_peduncle -0.013 0.012 -1.049 0.294 
Genomic acoustic_radiation -0.012 0.011 -1.147 0.251 
Genomic anterior_thalamic_radiation -0.014 0.011 -1.186 0.236 
Genomic 
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 Value Std. Error t-value p-value 
Genomic 
parahippocampal_part_of_cingulum -0.017 0.011 -1.552 0.121 
Genomic corticospinal_tract -0.016 0.011 -1.379 0.168 
Genomic 
inferior_fronto_occipital_fasciculus -0.025 0.012 -2.177 0.030 
Genomic 
inferior_longitudinal_fasciculus -0.024 0.012 -2.121 0.034 
Genomic medial_lemniscus 0.001 0.010 0.139 0.890 
Genomic posterior_thalamic_radiation -0.022 0.011 -2.002 0.045 
Genomic 
superior_longitudinal_fasciculus -0.026 0.012 -2.267 0.023 
Genomic superior_thalamic_radiation -0.014 0.012 -1.188 0.235 
Genomic uncinate_fasciculus -0.032 0.011 -2.915 0.004 
Genomic bl.FA.wm.forceps_major -0.033 0.012 -2.753 0.006 
Genomic bl.FA.wm.forceps_minor -0.031 0.012 -2.572 0.010 
Genomic 
bl.FA.wm.middle_cerebellar_peduncle -0.018 0.012 -1.465 0.143 
     
PGRS THRESHOLD: 1     
NETRIN1 acoustic_radiation 0.003 0.011 0.294 0.769 
NETRIN1 anterior_thalamic_radiation -0.023 0.011 -2.051 0.040 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.029 0.011 -2.720 0.007 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.692 0.489 
NETRIN1 corticospinal_tract 0.001 0.011 0.120 0.905 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.024 0.011 -2.070 0.039 
NETRIN1 
inferior_longitudinal_fasciculus -0.023 0.011 -1.978 0.048 
NETRIN1 medial_lemniscus -0.008 0.010 -0.757 0.449 
NETRIN1 
posterior_thalamic_radiation -0.015 0.011 -1.360 0.174 
NETRIN1 
superior_longitudinal_fasciculus -0.035 0.012 -3.017 0.003 
NETRIN1 
superior_thalamic_radiation -0.006 0.012 -0.517 0.605 
NETRIN1 uncinate_fasciculus -0.019 0.011 -1.799 0.072 
NETRIN1 forceps_major -0.016 0.012 -1.333 0.183 
NETRIN1 forceps_minor -0.018 0.012 -1.537 0.124 
NETRIN1 
middle_cerebellar_peduncle -0.016 0.012 -1.294 0.196 
Genomic acoustic_radiation -0.013 0.011 -1.230 0.219 
Genomic anterior_thalamic_radiation -0.016 0.011 -1.386 0.166 
Genomic 
cingulate_gyrus_part_of_cingulum -0.021 0.011 -1.943 0.052 
Genomic 
parahippocampal_part_of_cingulum -0.022 0.011 -2.022 0.043 
Genomic corticospinal_tract -0.018 0.011 -1.604 0.109 
Genomic 
inferior_fronto_occipital_fasciculus -0.028 0.012 -2.444 0.015 
Genomic 
inferior_longitudinal_fasciculus -0.025 0.012 -2.135 0.033 
Genomic medial_lemniscus -0.004 0.010 -0.401 0.689 
Genomic posterior_thalamic_radiation -0.022 0.011 -1.923 0.054 
Genomic 
superior_longitudinal_fasciculus -0.022 0.012 -1.927 0.054 
Genomic superior_thalamic_radiation -0.014 0.012 -1.202 0.229 
Genomic uncinate_fasciculus -0.032 0.011 -2.957 0.003 
Genomic forceps_major -0.031 0.012 -2.589 0.010 
Genomic forceps_minor -0.031 0.012 -2.573 0.010 
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Table S7. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on tract categories (FA) (N = 6,401). 
 
PGRS THRESHOLD: 0.01 Value Std. Error t-value p-value 
NETRIN1 gFA -0.025 0.012 -2.065 0.039 
NETRIN1 Association fibres -0.024 0.012 -2.024 0.043 
NETRIN1 Thalamic radiations -0.020 0.012 -1.615 0.106 
NETRIN1 Projection fibres -0.024 0.012 -1.963 0.050 
Genomic gFA -0.029 0.012 -2.431 0.015 
Genomic Association fibres -0.031 0.012 -2.574 0.010 
Genomic Thalamic radiations -0.020 0.012 -1.685 0.092 
Genomic Projection fibres -0.021 0.012 -1.716 0.086 
     
PGRS THRESHOLD: 0.05     
NETRIN1 gFA -0.012 0.012 -1.030 0.303 
NETRIN1 Association fibres -0.016 0.012 -1.333 0.183 
NETRIN1 Thalamic radiations -0.007 0.012 -0.590 0.555 
NETRIN1 Projection fibres -0.007 0.012 -0.552 0.581 
Genomic gFA -0.033 0.012 -2.776 0.006 
Genomic Association fibres -0.034 0.012 -2.845 0.004 
Genomic Thalamic radiations -0.026 0.012 -2.128 0.033 
Genomic Projection fibres -0.025 0.012 -2.073 0.038 
     
PGRS THRESHOLD: 0.1     
NETRIN1 gFA -0.018 0.012 -1.494 0.135 
NETRIN1 Association fibres -0.020 0.012 -1.684 0.092 
NETRIN1 Thalamic radiations -0.014 0.012 -1.125 0.261 
NETRIN1 Projection fibres -0.012 0.012 -1.032 0.302 
Genomic gFA -0.032 0.012 -2.656 0.008 
Genomic Association fibres -0.032 0.012 -2.728 0.006 
Genomic Thalamic radiations -0.022 0.012 -1.820 0.069 
Genomic Projection fibres -0.026 0.012 -2.201 0.028 
     
PGRS THRESHOLD: 1     
NETRIN1 gFA -0.027 0.012 -2.288 0.022 
NETRIN1 Association fibres -0.034 0.012 -2.903 0.004 
NETRIN1 Thalamic radiations -0.019 0.012 -1.590 0.112 
NETRIN1 Projection fibres -0.011 0.012 -0.881 0.379 
Genomic gFA -0.034 0.012 -2.824 0.005 
Genomic Association fibres -0.035 0.012 -2.927 0.003 
Genomic Thalamic radiations -0.023 0.012 -1.863 0.062 
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Table S8. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (FA) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 acoustic_radiation 0.002 0.011 0.222 0.824 
NETRIN1 anterior_thalamic_radiation -0.021 0.012 -1.800 0.072 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.024 0.011 -2.199 0.028 
NETRIN1 
parahippocampal_part_of_cingulum -0.008 0.011 -0.731 0.465 
NETRIN1 corticospinal_tract 0.001 0.011 0.125 0.900 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.022 0.012 -1.899 0.058 
NETRIN1 
inferior_longitudinal_fasciculus -0.021 0.012 -1.853 0.064 
NETRIN1 medial_lemniscus -0.009 0.010 -0.826 0.409 
NETRIN1 
posterior_thalamic_radiation -0.013 0.011 -1.162 0.245 
NETRIN1 
superior_longitudinal_fasciculus -0.034 0.012 -2.897 0.004 
NETRIN1 
superior_thalamic_radiation -0.006 0.012 -0.466 0.641 
NETRIN1 uncinate_fasciculus -0.019 0.011 -1.698 0.090 
NETRIN1 forceps_major -0.014 0.012 -1.197 0.231 
NETRIN1 forceps_minor -0.018 0.012 -1.489 0.136 
NETRIN1 
middle_cerebellar_peduncle -0.016 0.012 -1.270 0.204 
Genomic acoustic_radiation -0.016 0.011 -1.464 0.143 
Genomic anterior_thalamic_radiation -0.018 0.012 -1.530 0.126 
Genomic 
cingulate_gyrus_part_of_cingulum -0.020 0.011 -1.859 0.063 
Genomic 
parahippocampal_part_of_cingulum -0.022 0.011 -2.042 0.041 
Genomic corticospinal_tract -0.022 0.012 -1.878 0.060 
Genomic 
inferior_fronto_occipital_fasciculus -0.030 0.012 -2.579 0.010 
Genomic 
inferior_longitudinal_fasciculus -0.026 0.012 -2.258 0.024 
Genomic medial_lemniscus -0.006 0.011 -0.580 0.562 
Genomic posterior_thalamic_radiation -0.025 0.011 -2.224 0.026 
Genomic 
superior_longitudinal_fasciculus -0.025 0.012 -2.095 0.036 
Genomic superior_thalamic_radiation -0.018 0.012 -1.487 0.137 
Genomic uncinate_fasciculus -0.034 0.011 -3.111 0.002 
Genomic forceps_major -0.034 0.012 -2.781 0.005 
Genomic forceps_minor -0.033 0.012 -2.717 0.007 
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Table S9. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (FA) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 gFA -0.002 0.001 -2.197 0.028 
NETRIN1 Association fibres -0.002 0.001 -2.762 0.006 
NETRIN1 Thalamic radiations -0.001 0.000 -1.482 0.138 
NETRIN1 Projection fibres 0.000 0.001 -0.904 0.366 
Genomic gFA -0.002 0.001 -2.769 0.006 
Genomic Association fibres -0.002 0.001 -2.836 0.005 
Genomic Thalamic radiations -0.001 0.000 -1.855 0.064 




Table S10. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on individual white matter tracts (MD) (N = 6,390). 
 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 acoustic_radiation 0.008 0.011 0.772 0.440 
NETRIN1 anterior_thalamic_radiation 0.018 0.011 1.694 0.090 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.013 0.011 1.257 0.209 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.621 0.535 
NETRIN1 corticospinal_tract 0.003 0.011 0.270 0.787 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.021 0.011 1.905 0.057 
NETRIN1 
inferior_longitudinal_fasciculus 0.019 0.011 1.727 0.084 
NETRIN1 medial_lemniscus 0.007 0.011 0.659 0.510 
NETRIN1 posterior_thalamic_radiation 0.016 0.011 1.466 0.143 
NETRIN1 
superior_longitudinal_fasciculus 0.023 0.011 2.046 0.041 
NETRIN1 superior_thalamic_radiation 0.016 0.010 1.589 0.112 
NETRIN1 uncinate_fasciculus 0.011 0.010 1.033 0.302 
NETRIN1 bl.MD.wm.forceps_major 0.013 0.012 1.083 0.279 
NETRIN1 bl.MD.wm.forceps_minor 0.022 0.012 1.946 0.052 
NETRIN1 
bl.MD.wm.middle_cerebellar_peduncle 0.003 0.012 0.239 0.811 
Genomic acoustic_radiation 0.015 0.011 1.453 0.146 
Genomic anterior_thalamic_radiation 0.020 0.011 1.878 0.060 
Genomic 
cingulate_gyrus_part_of_cingulum 0.038 0.011 3.529 0.000 
Genomic 
parahippocampal_part_of_cingulum 0.030 0.011 2.846 0.004 
Genomic corticospinal_tract 0.030 0.011 2.654 0.008 
Genomic 
inferior_fronto_occipital_fasciculus 0.032 0.011 2.879 0.004 
Genomic 
inferior_longitudinal_fasciculus 0.029 0.011 2.618 0.009 
Genomic medial_lemniscus 0.012 0.011 1.145 0.252 
Genomic posterior_thalamic_radiation 0.016 0.011 1.493 0.135 
Genomic 
superior_longitudinal_fasciculus 0.028 0.011 2.490 0.013 
Genomic superior_thalamic_radiation 0.023 0.010 2.320 0.020 
Genomic uncinate_fasciculus 0.033 0.010 3.148 0.002 
Genomic bl.MD.wm.forceps_major 0.033 0.012 2.733 0.006 
Genomic bl.MD.wm.forceps_minor 0.020 0.012 1.692 0.091 
Genomic 
bl.MD.wm.middle_cerebellar_peduncle 0.004 0.012 0.362 0.718 
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 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.05     
NETRIN1 acoustic_radiation -0.006 0.010 -0.561 0.575 
NETRIN1 anterior_thalamic_radiation 0.015 0.011 1.426 0.154 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.354 0.176 
NETRIN1 
parahippocampal_part_of_cingulum 0.004 0.011 0.347 0.729 
NETRIN1 corticospinal_tract -0.003 0.011 -0.226 0.821 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.015 0.011 1.303 0.193 
NETRIN1 
inferior_longitudinal_fasciculus 0.017 0.011 1.538 0.124 
NETRIN1 medial_lemniscus 0.002 0.011 0.160 0.873 
NETRIN1 posterior_thalamic_radiation 0.016 0.011 1.509 0.131 
NETRIN1 
superior_longitudinal_fasciculus 0.023 0.011 1.998 0.046 
NETRIN1 superior_thalamic_radiation 0.014 0.010 1.420 0.156 
NETRIN1 uncinate_fasciculus 0.008 0.010 0.752 0.452 
NETRIN1 bl.MD.wm.forceps_major 0.014 0.012 1.172 0.241 
NETRIN1 bl.MD.wm.forceps_minor 0.015 0.012 1.292 0.196 
NETRIN1 
bl.MD.wm.middle_cerebellar_peduncle -0.002 0.012 -0.138 0.890 
Genomic acoustic_radiation 0.021 0.011 1.959 0.050 
Genomic anterior_thalamic_radiation 0.025 0.011 2.359 0.018 
Genomic 
cingulate_gyrus_part_of_cingulum 0.040 0.011 3.734 0.000 
Genomic 
parahippocampal_part_of_cingulum 0.033 0.011 3.108 0.002 
Genomic corticospinal_tract 0.034 0.011 2.999 0.003 
Genomic 
inferior_fronto_occipital_fasciculus 0.037 0.011 3.327 0.001 
Genomic 
inferior_longitudinal_fasciculus 0.032 0.011 2.890 0.004 
Genomic medial_lemniscus 0.012 0.011 1.091 0.275 
Genomic posterior_thalamic_radiation 0.016 0.011 1.527 0.127 
Genomic 
superior_longitudinal_fasciculus 0.032 0.011 2.819 0.005 
Genomic superior_thalamic_radiation 0.028 0.010 2.812 0.005 
Genomic uncinate_fasciculus 0.032 0.010 3.116 0.002 
Genomic bl.MD.wm.forceps_major 0.032 0.012 2.663 0.008 
Genomic bl.MD.wm.forceps_minor 0.024 0.012 2.103 0.036 
Genomic 
bl.MD.wm.middle_cerebellar_peduncle 0.006 0.012 0.515 0.607 
     
PGRS THRESHOLD: 0.1     
NETRIN1 acoustic_radiation -0.005 0.010 -0.458 0.647 
NETRIN1 anterior_thalamic_radiation 0.020 0.011 1.868 0.062 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.334 0.182 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.710 0.478 
NETRIN1 corticospinal_tract 0.002 0.011 0.204 0.838 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.020 0.011 1.800 0.072 
NETRIN1 
inferior_longitudinal_fasciculus 0.020 0.011 1.832 0.067 
NETRIN1 medial_lemniscus 0.011 0.011 1.018 0.309 
NETRIN1 posterior_thalamic_radiation 0.018 0.011 1.638 0.102 
NETRIN1 
superior_longitudinal_fasciculus 0.030 0.011 2.611 0.009 
NETRIN1 superior_thalamic_radiation 0.021 0.010 2.073 0.038 
NETRIN1 uncinate_fasciculus 0.009 0.010 0.879 0.379 
NETRIN1 forceps_major 0.017 0.012 1.407 0.159 
NETRIN1 forceps_minor 0.018 0.012 1.597 0.110 
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 Value Std. Error t-value p-value 
Genomic acoustic_radiation 0.022 0.011 2.107 0.035 
Genomic anterior_thalamic_radiation 0.023 0.011 2.143 0.032 
Genomic 
cingulate_gyrus_part_of_cingulum 0.038 0.011 3.601 0.000 
Genomic 
parahippocampal_part_of_cingulum 0.033 0.011 3.098 0.002 
Genomic corticospinal_tract 0.032 0.011 2.802 0.005 
Genomic 
inferior_fronto_occipital_fasciculus 0.034 0.011 3.081 0.002 
Genomic 
inferior_longitudinal_fasciculus 0.030 0.011 2.689 0.007 
Genomic medial_lemniscus 0.005 0.011 0.489 0.625 
Genomic posterior_thalamic_radiation 0.009 0.011 0.884 0.377 
Genomic 
superior_longitudinal_fasciculus 0.030 0.011 2.617 0.009 
Genomic superior_thalamic_radiation 0.024 0.010 2.442 0.015 
Genomic uncinate_fasciculus 0.034 0.010 3.320 0.001 
Genomic forceps_major 0.028 0.012 2.358 0.018 
Genomic forceps_minor 0.021 0.012 1.783 0.075 
Genomic middle_cerebellar_peduncle 0.008 0.012 0.666 0.505 
     
PGRS THRESHOLD: 1     
NETRIN1 acoustic_radiation 0.004 0.010 0.347 0.729 
NETRIN1 anterior_thalamic_radiation 0.028 0.011 2.669 0.008 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.022 0.011 2.023 0.043 
NETRIN1 
parahippocampal_part_of_cingulum 0.000 0.011 -0.023 0.981 
NETRIN1 corticospinal_tract 0.017 0.011 1.525 0.127 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.028 0.011 2.551 0.011 
NETRIN1 
inferior_longitudinal_fasciculus 0.029 0.011 2.553 0.011 
NETRIN1 medial_lemniscus 0.005 0.011 0.428 0.669 
NETRIN1 posterior_thalamic_radiation 0.026 0.011 2.453 0.014 
NETRIN1 
superior_longitudinal_fasciculus 0.033 0.011 2.953 0.003 
NETRIN1 superior_thalamic_radiation 0.027 0.010 2.763 0.006 
NETRIN1 uncinate_fasciculus 0.020 0.010 1.900 0.058 
NETRIN1 forceps_major 0.018 0.012 1.519 0.129 
NETRIN1 forceps_minor 0.021 0.012 1.791 0.073 
NETRIN1 middle_cerebellar_peduncle 0.011 0.012 0.890 0.373 
Genomic acoustic_radiation 0.019 0.011 1.841 0.066 
Genomic anterior_thalamic_radiation 0.021 0.011 2.021 0.043 
Genomic 
cingulate_gyrus_part_of_cingulum 0.036 0.011 3.332 0.001 
Genomic 
parahippocampal_part_of_cingulum 0.034 0.011 3.223 0.001 
Genomic corticospinal_tract 0.023 0.011 1.997 0.046 
Genomic 
inferior_fronto_occipital_fasciculus 0.032 0.011 2.828 0.005 
Genomic 
inferior_longitudinal_fasciculus 0.025 0.011 2.262 0.024 
Genomic medial_lemniscus 0.005 0.011 0.470 0.639 
Genomic posterior_thalamic_radiation 0.002 0.011 0.142 0.887 
Genomic 
superior_longitudinal_fasciculus 0.024 0.011 2.156 0.031 
Genomic superior_thalamic_radiation 0.018 0.010 1.804 0.071 
Genomic uncinate_fasciculus 0.030 0.010 2.844 0.004 
Genomic forceps_major 0.029 0.012 2.447 0.014 
Genomic forceps_minor 0.021 0.012 1.858 0.063 
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Table S11. The effect of unpruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 
0.1, 0.5 and 1 on tract categories (MD) (N = 6,390). 
 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 gMD 0.018 0.012 1.574 0.116 
NETRIN1 Association fibres 0.013 0.012 1.086 0.277 
NETRIN1 Thalamic radiations 0.019 0.011 1.781 0.075 
NETRIN1 Projection fibres 0.013 0.012 1.087 0.277 
Genomic gMD 0.037 0.012 3.248 0.001 
Genomic Association fibres 0.043 0.012 3.707 0.000 
Genomic Thalamic radiations 0.022 0.011 2.027 0.043 
Genomic Projection fibres 0.026 0.012 2.180 0.029 
     
PGRS THRESHOLD: 0.05     
NETRIN1 gMD 0.016 0.011 1.380 0.168 
NETRIN1 Association fibres 0.015 0.012 1.320 0.187 
NETRIN1 Thalamic radiations 0.018 0.011 1.669 0.095 
NETRIN1 Projection fibres 0.004 0.012 0.322 0.748 
Genomic gMD 0.041 0.011 3.607 0.000 
Genomic Association fibres 0.047 0.012 4.033 0.000 
Genomic Thalamic radiations 0.025 0.011 2.334 0.020 
Genomic Projection fibres 0.030 0.012 2.478 0.013 
     
PGRS THRESHOLD: 0.1     
NETRIN1 gMD 0.018 0.011 1.596 0.111 
NETRIN1 Association fibres 0.013 0.012 1.106 0.269 
NETRIN1 Thalamic radiations 0.022 0.011 2.055 0.040 
NETRIN1 Projection fibres 0.011 0.012 0.920 0.358 
Genomic gMD 0.038 0.011 3.342 0.001 
Genomic Association fibres 0.046 0.012 3.934 0.000 
Genomic Thalamic radiations 0.020 0.011 1.822 0.069 
Genomic Projection fibres 0.029 0.012 2.391 0.017 
     
PGRS THRESHOLD: 1     
NETRIN1 gMD 0.029 0.011 2.524 0.012 
NETRIN1 Association fibres 0.023 0.012 2.014 0.044 
NETRIN1 Thalamic radiations 0.031 0.011 2.944 0.003 
NETRIN1 Projection fibres 0.020 0.012 1.686 0.092 
Genomic gMD 0.034 0.011 2.974 0.003 
Genomic Association fibres 0.043 0.012 3.666 0.000 
Genomic Thalamic radiations 0.013 0.011 1.229 0.219 
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Table S12. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (MD) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 acoustic_radiation 0.005 0.011 0.484 0.628 
NETRIN1 anterior_thalamic_radiation 0.023 0.011 2.171 0.030 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.019 0.011 1.682 0.093 
NETRIN1 
parahippocampal_part_of_cingulum 0.000 0.011 -0.004 0.997 
NETRIN1 corticospinal_tract 0.014 0.012 1.232 0.218 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.025 0.011 2.242 0.025 
NETRIN1 
inferior_longitudinal_fasciculus 0.027 0.011 2.377 0.017 
NETRIN1 medial_lemniscus 0.003 0.011 0.288 0.774 
NETRIN1 posterior_thalamic_radiation 0.024 0.011 2.213 0.027 
NETRIN1 
superior_longitudinal_fasciculus 0.030 0.011 2.649 0.008 
NETRIN1 superior_thalamic_radiation 0.024 0.010 2.345 0.019 
NETRIN1 uncinate_fasciculus 0.017 0.011 1.559 0.119 
NETRIN1 forceps_major 0.019 0.012 1.599 0.110 
NETRIN1 forceps_minor 0.019 0.012 1.592 0.111 
NETRIN1 middle_cerebellar_peduncle 0.012 0.012 0.984 0.325 
Genomic acoustic_radiation 0.010 0.011 0.949 0.342 
Genomic anterior_thalamic_radiation 0.011 0.011 1.009 0.313 
Genomic 
cingulate_gyrus_part_of_cingulum 0.021 0.011 1.852 0.064 
Genomic 
parahippocampal_part_of_cingulum 0.027 0.011 2.485 0.013 
Genomic corticospinal_tract 0.009 0.012 0.800 0.424 
Genomic 
inferior_fronto_occipital_fasciculus 0.019 0.011 1.630 0.103 
Genomic 
inferior_longitudinal_fasciculus 0.013 0.011 1.138 0.255 
Genomic medial_lemniscus -0.004 0.011 -0.378 0.705 
Genomic posterior_thalamic_radiation -0.006 0.011 -0.505 0.613 
Genomic 
superior_longitudinal_fasciculus 0.013 0.012 1.113 0.266 
Genomic superior_thalamic_radiation 0.007 0.011 0.653 0.514 
Genomic uncinate_fasciculus 0.017 0.011 1.588 0.112 
Genomic forceps_major 0.020 0.012 1.624 0.104 
Genomic forceps_minor 0.012 0.012 0.982 0.326 




Table S13. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (MD) (N = 6,320). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 gMD 3.4E-06 1.4E-06 2.4E+00 1.6E-02 
NETRIN1 Association fibres 2.0E-06 1.1E-06 1.9E+00 5.8E-02 
NETRIN1 Thalamic radiations 2.2E-06 7.9E-07 2.8E+00 5.4E-03 
NETRIN1 Projection fibres 1.4E-06 8.0E-07 1.8E+00 7.7E-02 
Genomic gMD 4.2E-06 1.4E-06 2.9E+00 3.5E-03 
Genomic Association fibres 3.9E-06 1.1E-06 3.6E+00 3.3E-04 
Genomic Thalamic radiations 9.8E-07 7.9E-07 1.2E+00 2.2E-01 
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Table S14. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on individual white matter tracts (FA) (N = 6,401). 
 
Pruned NETRIN1- and Genomic-PRS with outliers included (6,420) and outliers excluded 
(6,401 for FA and 6,390 for MD) at all 5 thresholds (0.01, 0.05, 0.1, 0.5, 1) 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 acoustic_radiation -0.004 0.011 -0.349 0.727 
NETRIN1 anterior_thalamic_radiation -0.020 0.011 -1.709 0.087 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.008 0.011 -0.704 0.482 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.641 0.521 
NETRIN1 corticospinal_tract -0.022 0.011 -1.923 0.055 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.024 0.012 -2.058 0.040 
NETRIN1 
inferior_longitudinal_fasciculus -0.024 0.012 -2.047 0.041 
NETRIN1 medial_lemniscus -0.012 0.010 -1.131 0.258 
NETRIN1 
posterior_thalamic_radiation -0.014 0.011 -1.238 0.216 
NETRIN1 
superior_longitudinal_fasciculus -0.028 0.012 -2.408 0.016 
NETRIN1 
superior_thalamic_radiation -0.020 0.012 -1.677 0.094 
NETRIN1 uncinate_fasciculus -0.023 0.011 -2.156 0.031 
NETRIN1 bl.FA.wm.forceps_major -0.014 0.012 -1.137 0.255 
NETRIN1 bl.FA.wm.forceps_minor -0.009 0.012 -0.784 0.433 
NETRIN1 
bl.FA.wm.middle_cerebellar_peduncle -0.028 0.012 -2.257 0.024 
Genomic acoustic_radiation -0.010 0.011 -0.942 0.346 
Genomic anterior_thalamic_radiation -0.017 0.011 -1.440 0.150 
Genomic 
cingulate_gyrus_part_of_cingulum -0.008 0.011 -0.785 0.432 
Genomic 
parahippocampal_part_of_cingulum 0.009 0.011 0.810 0.418 
Genomic corticospinal_tract -0.010 0.011 -0.889 0.374 
Genomic 
inferior_fronto_occipital_fasciculus -0.014 0.012 -1.249 0.212 
Genomic 
inferior_longitudinal_fasciculus -0.012 0.012 -1.023 0.306 
Genomic medial_lemniscus 0.000 0.010 0.010 0.992 
Genomic posterior_thalamic_radiation -0.011 0.011 -0.965 0.335 
Genomic 
superior_longitudinal_fasciculus -0.013 0.012 -1.080 0.280 
Genomic superior_thalamic_radiation -0.016 0.012 -1.332 0.183 
Genomic uncinate_fasciculus -0.019 0.011 -1.793 0.073 
Genomic bl.FA.wm.forceps_major -0.013 0.012 -1.086 0.278 
Genomic bl.FA.wm.forceps_minor -0.018 0.012 -1.475 0.140 
Genomic 
bl.FA.wm.middle_cerebellar_peduncle 0.017 0.012 1.369 0.171 
     
PGRS THRESHOLD: 0.05     
NETRIN1 acoustic_radiation 0.008 0.011 0.770 0.441 
NETRIN1 anterior_thalamic_radiation -0.012 0.011 -1.047 0.295 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.007 0.011 -0.627 0.531 
NETRIN1 
parahippocampal_part_of_cingulum -0.014 0.011 -1.335 0.182 
NETRIN1 corticospinal_tract -0.002 0.011 -0.146 0.884 
NETRIN1 













Barbu et al.  Supplement 
20 
 Value Std. Error t-value p-value 
NETRIN1 
inferior_longitudinal_fasciculus -0.010 0.011 -0.865 0.387 
NETRIN1 medial_lemniscus -0.006 0.010 -0.574 0.566 
NETRIN1 
posterior_thalamic_radiation -0.003 0.011 -0.304 0.761 
NETRIN1 
superior_longitudinal_fasciculus -0.015 0.012 -1.290 0.197 
NETRIN1 
superior_thalamic_radiation -0.003 0.012 -0.275 0.783 
NETRIN1 uncinate_fasciculus -0.011 0.011 -1.030 0.303 
NETRIN1 bl.FA.wm.forceps_major -0.004 0.012 -0.292 0.770 
NETRIN1 bl.FA.wm.forceps_minor -0.002 0.012 -0.178 0.858 
NETRIN1 
bl.FA.wm.middle_cerebellar_peduncle -0.015 0.012 -1.200 0.230 
Genomic acoustic_radiation -0.005 0.011 -0.462 0.644 
Genomic anterior_thalamic_radiation -0.010 0.011 -0.901 0.367 
Genomic 
cingulate_gyrus_part_of_cingulum -0.004 0.011 -0.350 0.726 
Genomic 
parahippocampal_part_of_cingulum 0.001 0.011 0.103 0.918 
Genomic corticospinal_tract -0.014 0.011 -1.272 0.203 
Genomic 
inferior_fronto_occipital_fasciculus -0.016 0.011 -1.351 0.177 
Genomic 
inferior_longitudinal_fasciculus -0.015 0.011 -1.281 0.200 
Genomic medial_lemniscus -0.006 0.010 -0.569 0.569 
Genomic posterior_thalamic_radiation -0.019 0.011 -1.716 0.086 
Genomic 
superior_longitudinal_fasciculus -0.012 0.012 -1.076 0.282 
Genomic superior_thalamic_radiation -0.019 0.012 -1.596 0.110 
Genomic uncinate_fasciculus -0.017 0.011 -1.557 0.119 
Genomic bl.FA.wm.forceps_major -0.013 0.012 -1.093 0.275 
Genomic bl.FA.wm.forceps_minor -0.014 0.012 -1.186 0.236 
Genomic 
bl.FA.wm.middle_cerebellar_peduncle -0.003 0.012 -0.271 0.786 
     
PGRS THRESHOLD: 0.1     
NETRIN1 acoustic_radiation 0.005 0.011 0.452 0.652 
NETRIN1 anterior_thalamic_radiation -0.017 0.011 -1.442 0.149 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.013 0.011 -1.238 0.216 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.681 0.496 
NETRIN1 corticospinal_tract -0.003 0.011 -0.225 0.822 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.016 0.012 -1.381 0.167 
NETRIN1 
inferior_longitudinal_fasciculus -0.014 0.012 -1.221 0.222 
NETRIN1 medial_lemniscus -0.018 0.010 -1.730 0.084 
NETRIN1 
posterior_thalamic_radiation -0.007 0.011 -0.601 0.548 
NETRIN1 
superior_longitudinal_fasciculus -0.026 0.012 -2.205 0.027 
NETRIN1 
superior_thalamic_radiation -0.010 0.012 -0.871 0.384 
NETRIN1 uncinate_fasciculus -0.010 0.011 -0.896 0.370 
NETRIN1 forceps_major -0.012 0.012 -1.004 0.316 
NETRIN1 forceps_minor -0.013 0.012 -1.041 0.298 
NETRIN1 
middle_cerebellar_peduncle -0.011 0.012 -0.922 0.356 
Genomic acoustic_radiation 0.001 0.011 0.080 0.936 
Genomic anterior_thalamic_radiation 0.002 0.011 0.146 0.884 
Genomic 
cingulate_gyrus_part_of_cingulum -0.001 0.011 -0.075 0.940 
Genomic 
parahippocampal_part_of_cingulum -0.002 0.011 -0.188 0.851 
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 Value Std. Error t-value p-value 
Genomic 
inferior_fronto_occipital_fasciculus -0.008 0.011 -0.723 0.469 
Genomic 
inferior_longitudinal_fasciculus -0.009 0.012 -0.760 0.447 
Genomic medial_lemniscus -0.001 0.010 -0.131 0.896 
Genomic posterior_thalamic_radiation -0.009 0.011 -0.770 0.441 
Genomic 
superior_longitudinal_fasciculus -0.007 0.012 -0.580 0.562 
Genomic superior_thalamic_radiation -0.011 0.012 -0.951 0.342 
Genomic uncinate_fasciculus -0.017 0.011 -1.572 0.116 
Genomic forceps_major -0.008 0.012 -0.632 0.528 
Genomic forceps_minor -0.006 0.012 -0.518 0.605 
Genomic middle_cerebellar_peduncle -0.016 0.012 -1.281 0.200 
     
PGRS THRESHOLD: 0.5     
NETRIN1 acoustic_radiation 0.006 0.011 0.520 0.603 
NETRIN1 anterior_thalamic_radiation -0.021 0.011 -1.811 0.070 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.023 0.011 -2.201 0.028 
NETRIN1 
parahippocampal_part_of_cingulum -0.006 0.011 -0.583 0.560 
NETRIN1 corticospinal_tract 0.002 0.011 0.204 0.839 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.021 0.011 -1.824 0.068 
NETRIN1 
inferior_longitudinal_fasciculus -0.021 0.012 -1.790 0.074 
NETRIN1 medial_lemniscus -0.011 0.010 -1.061 0.289 
NETRIN1 
posterior_thalamic_radiation -0.011 0.011 -0.981 0.327 
NETRIN1 
superior_longitudinal_fasciculus -0.035 0.012 -3.031 0.002 
NETRIN1 
superior_thalamic_radiation -0.006 0.012 -0.521 0.603 
NETRIN1 uncinate_fasciculus -0.018 0.011 -1.702 0.089 
NETRIN1 forceps_major -0.009 0.012 -0.740 0.459 
NETRIN1 forceps_minor -0.013 0.012 -1.071 0.284 
NETRIN1 
middle_cerebellar_peduncle -0.017 0.012 -1.363 0.173 
Genomic acoustic_radiation -0.005 0.011 -0.488 0.625 
Genomic anterior_thalamic_radiation -0.007 0.011 -0.607 0.544 
Genomic 
cingulate_gyrus_part_of_cingulum -0.008 0.011 -0.780 0.435 
Genomic 
parahippocampal_part_of_cingulum -0.013 0.011 -1.189 0.235 
Genomic corticospinal_tract -0.022 0.011 -1.926 0.054 
Genomic 
inferior_fronto_occipital_fasciculus -0.018 0.011 -1.581 0.114 
Genomic 
inferior_longitudinal_fasciculus -0.014 0.012 -1.242 0.214 
Genomic medial_lemniscus -0.011 0.010 -1.055 0.291 
Genomic posterior_thalamic_radiation -0.015 0.011 -1.346 0.178 
Genomic 
superior_longitudinal_fasciculus -0.012 0.012 -1.014 0.311 
Genomic superior_thalamic_radiation -0.016 0.012 -1.381 0.167 
Genomic uncinate_fasciculus -0.023 0.011 -2.172 0.030 
Genomic forceps_major -0.015 0.012 -1.270 0.204 
Genomic forceps_minor -0.014 0.012 -1.184 0.237 
Genomic middle_cerebellar_peduncle -0.016 0.012 -1.334 0.182 
     
PGRS THRESHOLD: 1     
NETRIN1 acoustic_radiation 0.006 0.011 0.554 0.579 
NETRIN1 anterior_thalamic_radiation -0.022 0.011 -1.896 0.058 
NETRIN1 
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 Value Std. Error t-value p-value 
NETRIN1 
parahippocampal_part_of_cingulum -0.006 0.011 -0.558 0.577 
NETRIN1 corticospinal_tract -0.001 0.011 -0.057 0.954 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.020 0.011 -1.765 0.078 
NETRIN1 
inferior_longitudinal_fasciculus -0.019 0.011 -1.629 0.103 
NETRIN1 medial_lemniscus -0.011 0.010 -1.020 0.308 
NETRIN1 
posterior_thalamic_radiation -0.011 0.011 -0.991 0.322 
NETRIN1 
superior_longitudinal_fasciculus -0.034 0.012 -2.959 0.003 
NETRIN1 
superior_thalamic_radiation -0.007 0.012 -0.582 0.560 
NETRIN1 uncinate_fasciculus -0.018 0.011 -1.635 0.102 
NETRIN1 forceps_major -0.008 0.012 -0.678 0.497 
NETRIN1 forceps_minor -0.013 0.012 -1.116 0.264 
NETRIN1 
middle_cerebellar_peduncle -0.015 0.012 -1.195 0.232 
Genomic acoustic_radiation -0.005 0.011 -0.502 0.616 
Genomic anterior_thalamic_radiation -0.009 0.011 -0.755 0.450 
Genomic 
cingulate_gyrus_part_of_cingulum -0.010 0.011 -0.976 0.329 
Genomic 
parahippocampal_part_of_cingulum -0.015 0.011 -1.373 0.170 
Genomic corticospinal_tract -0.021 0.011 -1.826 0.068 
Genomic 
inferior_fronto_occipital_fasciculus -0.018 0.011 -1.588 0.112 
Genomic 
inferior_longitudinal_fasciculus -0.014 0.011 -1.231 0.218 
Genomic medial_lemniscus -0.011 0.010 -1.044 0.296 
Genomic posterior_thalamic_radiation -0.013 0.011 -1.151 0.250 
Genomic 
superior_longitudinal_fasciculus -0.010 0.012 -0.848 0.396 
Genomic superior_thalamic_radiation -0.015 0.012 -1.263 0.207 
Genomic uncinate_fasciculus -0.024 0.011 -2.174 0.030 
Genomic forceps_major -0.014 0.012 -1.167 0.243 
Genomic forceps_minor -0.012 0.012 -1.017 0.309 
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Table S15. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on tract categories (FA) (N = 6,401). 
 
PGRS THRESHOLD: 0.01 Value Std. Error t-value p-value 
NETRIN1 gFA -0.026 0.012 -2.186 0.029 
NETRIN1 Association fibres -0.025 0.012 -2.066 0.039 
NETRIN1 Thalamic radiations -0.022 0.012 -1.853 0.064 
NETRIN1 Projection fibres -0.025 0.012 -2.098 0.036 
Genomic gFA -0.015 0.012 -1.226 0.220 
Genomic Association fibres -0.013 0.012 -1.068 0.285 
Genomic Thalamic radiations -0.018 0.012 -1.488 0.137 
Genomic Projection fibres -0.009 0.012 -0.766 0.444 
     
PGRS THRESHOLD: 0.05 Value Std. Error t-value p-value 
NETRIN1 gFA -0.011 0.012 -0.943 0.346 
NETRIN1 Association fibres -0.015 0.012 -1.245 0.213 
NETRIN1 Thalamic radiations -0.008 0.012 -0.635 0.526 
NETRIN1 Projection fibres -0.004 0.012 -0.367 0.714 
Genomic gFA -0.017 0.012 -1.385 0.166 
Genomic Association fibres -0.013 0.012 -1.074 0.283 
Genomic Thalamic radiations -0.021 0.012 -1.740 0.082 
Genomic Projection fibres -0.015 0.012 -1.283 0.200 
     
PGRS THRESHOLD: 0.1 Value Std. Error t-value p-value 
NETRIN1 gFA -0.018 0.012 -1.518 0.129 
NETRIN1 Association fibres -0.020 0.012 -1.720 0.085 
NETRIN1 Thalamic radiations -0.014 0.012 -1.147 0.251 
NETRIN1 Projection fibres -0.012 0.012 -0.981 0.327 
Genomic gFA -0.010 0.012 -0.855 0.393 
Genomic Association fibres -0.008 0.012 -0.714 0.476 
Genomic Thalamic radiations -0.008 0.012 -0.666 0.505 
Genomic Projection fibres -0.013 0.012 -1.105 0.269 
     
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 gFA -0.023 0.012 -1.966 0.049 
NETRIN1 Association fibres -0.031 0.012 -2.567 0.010 
NETRIN1 Thalamic radiations -0.016 0.012 -1.327 0.184 
NETRIN1 Projection fibres -0.008 0.012 -0.668 0.504 
Genomic gFA -0.021 0.012 -1.794 0.073 
Genomic Association fibres -0.020 0.012 -1.656 0.098 
Genomic Thalamic radiations -0.017 0.012 -1.376 0.169 
Genomic Projection fibres -0.024 0.012 -1.983 0.047 
     
PGRS THRESHOLD: 1 Value Std. Error t-value p-value 
NETRIN1 gFA -0.024 0.012 -1.991 0.047 
NETRIN1 Association fibres -0.031 0.012 -2.585 0.010 
NETRIN1 Thalamic radiations -0.017 0.012 -1.387 0.166 
NETRIN1 Projection fibres -0.009 0.012 -0.715 0.475 
Genomic gFA -0.021 0.012 -1.793 0.073 
Genomic Association fibres -0.021 0.012 -1.741 0.082 
Genomic Thalamic radiations -0.016 0.012 -1.296 0.195 
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Table S16. The effect of pruned NETRIN1- and Genomic-PRS at threshold 0.5 on individual 
white matter tracts (FA) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 acoustic_radiation 0.002 0.011 0.198 0.843 
NETRIN1 anterior_thalamic_radiation -0.022 0.012 -1.922 0.055 
NETRIN1 
cingulate_gyrus_part_of_cingulum -0.024 0.011 -2.234 0.025 
NETRIN1 
parahippocampal_part_of_cingulum -0.007 0.011 -0.644 0.520 
NETRIN1 corticospinal_tract -0.001 0.011 -0.100 0.920 
NETRIN1 
inferior_fronto_occipital_fasciculus -0.023 0.012 -1.957 0.050 
NETRIN1 
inferior_longitudinal_fasciculus -0.022 0.012 -1.865 0.062 
NETRIN1 medial_lemniscus -0.013 0.011 -1.240 0.215 
NETRIN1 
posterior_thalamic_radiation -0.013 0.011 -1.120 0.263 
NETRIN1 
superior_longitudinal_fasciculus -0.035 0.012 -3.029 0.002 
NETRIN1 
superior_thalamic_radiation -0.008 0.012 -0.693 0.488 
NETRIN1 uncinate_fasciculus -0.020 0.011 -1.841 0.066 
NETRIN1 forceps_major -0.011 0.012 -0.908 0.364 
NETRIN1 forceps_minor -0.016 0.012 -1.299 0.194 
NETRIN1 
middle_cerebellar_peduncle -0.017 0.012 -1.360 0.174 
Genomic acoustic_radiation -0.008 0.011 -0.773 0.439 
Genomic anterior_thalamic_radiation -0.010 0.012 -0.894 0.371 
Genomic 
cingulate_gyrus_part_of_cingulum -0.010 0.011 -0.925 0.355 
Genomic 
parahippocampal_part_of_cingulum -0.014 0.011 -1.309 0.191 
Genomic corticospinal_tract -0.025 0.012 -2.154 0.031 
Genomic 
inferior_fronto_occipital_fasciculus -0.021 0.012 -1.758 0.079 
Genomic 
inferior_longitudinal_fasciculus -0.017 0.012 -1.436 0.151 
Genomic medial_lemniscus -0.015 0.011 -1.382 0.167 
Genomic posterior_thalamic_radiation -0.018 0.011 -1.586 0.113 
Genomic 
superior_longitudinal_fasciculus -0.014 0.012 -1.193 0.233 
Genomic superior_thalamic_radiation -0.019 0.012 -1.613 0.107 
Genomic uncinate_fasciculus -0.025 0.011 -2.284 0.022 
Genomic forceps_major -0.019 0.012 -1.521 0.128 
Genomic forceps_minor -0.017 0.012 -1.370 0.171 
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Table S17. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (FA) (N = 6,420). 
 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 gFA -0.002 0.001 -1.966 0.049 
NETRIN1 Association fibres -0.002 0.001 -2.567 0.010 
NETRIN1 Thalamic radiations -0.001 0.000 -1.327 0.184 
NETRIN1 Projection fibres 0.000 0.001 -0.668 0.504 
Genomic gFA -0.002 0.001 -1.794 0.073 
Genomic Association fibres -0.001 0.001 -1.656 0.098 
Genomic Thalamic radiations -0.001 0.000 -1.376 0.169 




Table S18. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on individual white matter tracts (MD) (N = 6,390). 
 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 acoustic_radiation 0.006 0.011 0.544 0.586 
NETRIN1 anterior_thalamic_radiation 0.008 0.011 0.773 0.439 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.013 0.011 1.241 0.215 
NETRIN1 
parahippocampal_part_of_cingulum -0.012 0.011 -1.116 0.264 
NETRIN1 corticospinal_tract -0.002 0.011 -0.206 0.837 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.017 0.011 1.482 0.138 
NETRIN1 
inferior_longitudinal_fasciculus 0.017 0.011 1.543 0.123 
NETRIN1 medial_lemniscus 0.013 0.011 1.225 0.220 
NETRIN1 posterior_thalamic_radiation 0.008 0.011 0.773 0.439 
NETRIN1 
superior_longitudinal_fasciculus 0.018 0.011 1.556 0.120 
NETRIN1 superior_thalamic_radiation 0.008 0.010 0.851 0.395 
NETRIN1 uncinate_fasciculus 0.014 0.010 1.387 0.165 
NETRIN1 bl.MD.wm.forceps_major 0.009 0.012 0.741 0.459 
NETRIN1 bl.MD.wm.forceps_minor 0.016 0.012 1.390 0.165 
NETRIN1 
bl.MD.wm.middle_cerebellar_peduncle -0.004 0.012 -0.350 0.726 
Genomic acoustic_radiation -0.004 0.011 -0.353 0.724 
Genomic anterior_thalamic_radiation 0.019 0.011 1.833 0.067 
Genomic 
cingulate_gyrus_part_of_cingulum 0.024 0.011 2.263 0.024 
Genomic 
parahippocampal_part_of_cingulum 0.008 0.011 0.715 0.475 
Genomic corticospinal_tract 0.012 0.011 1.041 0.298 
Genomic 
inferior_fronto_occipital_fasciculus 0.019 0.011 1.711 0.087 
Genomic 
inferior_longitudinal_fasciculus 0.008 0.011 0.758 0.449 
Genomic medial_lemniscus 0.001 0.011 0.117 0.907 
Genomic posterior_thalamic_radiation -0.001 0.011 -0.100 0.920 
Genomic 
superior_longitudinal_fasciculus 0.017 0.011 1.503 0.133 
Genomic superior_thalamic_radiation 0.018 0.010 1.831 0.067 
Genomic uncinate_fasciculus 0.023 0.010 2.213 0.027 
Genomic bl.MD.wm.forceps_major 0.014 0.012 1.138 0.255 
Genomic bl.MD.wm.forceps_minor 0.018 0.012 1.602 0.109 
Genomic 
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 Value Std. Error t-value p-value 
     
PGRS THRESHOLD: 0.05     
NETRIN1 acoustic_radiation -0.010 0.010 -0.947 0.344 
NETRIN1 anterior_thalamic_radiation 0.006 0.011 0.571 0.568 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.273 0.203 
NETRIN1 
parahippocampal_part_of_cingulum 0.001 0.011 0.082 0.935 
NETRIN1 corticospinal_tract -0.006 0.011 -0.575 0.565 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.010 0.011 0.883 0.377 
NETRIN1 
inferior_longitudinal_fasciculus 0.014 0.011 1.274 0.203 
NETRIN1 medial_lemniscus 0.004 0.011 0.395 0.693 
NETRIN1 posterior_thalamic_radiation 0.011 0.011 0.993 0.321 
NETRIN1 
superior_longitudinal_fasciculus 0.018 0.011 1.549 0.122 
NETRIN1 superior_thalamic_radiation 0.007 0.010 0.741 0.458 
NETRIN1 uncinate_fasciculus 0.008 0.010 0.780 0.435 
NETRIN1 bl.MD.wm.forceps_major 0.011 0.012 0.937 0.349 
NETRIN1 bl.MD.wm.forceps_minor 0.009 0.012 0.752 0.452 
NETRIN1 
bl.MD.wm.middle_cerebellar_peduncle -0.007 0.012 -0.600 0.549 
Genomic acoustic_radiation 0.004 0.010 0.428 0.669 
Genomic anterior_thalamic_radiation 0.018 0.011 1.754 0.079 
Genomic 
cingulate_gyrus_part_of_cingulum 0.021 0.011 1.993 0.046 
Genomic 
parahippocampal_part_of_cingulum 0.013 0.011 1.222 0.222 
Genomic corticospinal_tract 0.019 0.011 1.674 0.094 
Genomic 
inferior_fronto_occipital_fasciculus 0.024 0.011 2.168 0.030 
Genomic 
inferior_longitudinal_fasciculus 0.013 0.011 1.160 0.246 
Genomic medial_lemniscus 0.008 0.011 0.724 0.469 
Genomic posterior_thalamic_radiation 0.001 0.011 0.091 0.928 
Genomic 
superior_longitudinal_fasciculus 0.017 0.011 1.492 0.136 
Genomic superior_thalamic_radiation 0.017 0.010 1.735 0.083 
Genomic uncinate_fasciculus 0.015 0.010 1.418 0.156 
Genomic bl.MD.wm.forceps_major 0.016 0.012 1.298 0.194 
Genomic bl.MD.wm.forceps_minor 0.020 0.012 1.703 0.089 
Genomic 
bl.MD.wm.middle_cerebellar_peduncle 0.010 0.012 0.791 0.429 
     
PGRS THRESHOLD: 0.1     
NETRIN1 acoustic_radiation -0.008 0.011 -0.727 0.468 
NETRIN1 anterior_thalamic_radiation 0.014 0.011 1.297 0.195 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.352 0.176 
NETRIN1 
parahippocampal_part_of_cingulum -0.009 0.011 -0.899 0.369 
NETRIN1 corticospinal_tract -0.001 0.011 -0.071 0.943 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.018 0.011 1.641 0.101 
NETRIN1 
inferior_longitudinal_fasciculus 0.020 0.011 1.774 0.076 
NETRIN1 medial_lemniscus 0.015 0.011 1.377 0.169 
NETRIN1 posterior_thalamic_radiation 0.014 0.011 1.334 0.182 
NETRIN1 
superior_longitudinal_fasciculus 0.027 0.011 2.413 0.016 
NETRIN1 superior_thalamic_radiation 0.016 0.010 1.652 0.099 
NETRIN1 uncinate_fasciculus 0.010 0.010 0.991 0.321 
NETRIN1 forceps_major 0.014 0.012 1.205 0.228 
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 Value Std. Error t-value p-value 
NETRIN1 middle_cerebellar_peduncle 0.004 0.012 0.359 0.720 
Genomic acoustic_radiation 0.002 0.011 0.161 0.872 
Genomic anterior_thalamic_radiation 0.011 0.011 1.023 0.306 
Genomic 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.306 0.191 
Genomic 
parahippocampal_part_of_cingulum 0.016 0.011 1.537 0.124 
Genomic corticospinal_tract 0.013 0.011 1.167 0.243 
Genomic 
inferior_fronto_occipital_fasciculus 0.014 0.011 1.228 0.219 
Genomic 
inferior_longitudinal_fasciculus 0.006 0.011 0.516 0.606 
Genomic medial_lemniscus -0.003 0.011 -0.323 0.747 
Genomic posterior_thalamic_radiation -0.008 0.011 -0.791 0.429 
Genomic 
superior_longitudinal_fasciculus 0.009 0.011 0.832 0.405 
Genomic superior_thalamic_radiation 0.008 0.010 0.776 0.438 
Genomic uncinate_fasciculus 0.013 0.010 1.246 0.213 
Genomic forceps_major 0.009 0.012 0.751 0.453 
Genomic forceps_minor 0.010 0.012 0.852 0.394 
Genomic middle_cerebellar_peduncle 0.009 0.012 0.712 0.476 
     
PGRS THRESHOLD: 0.5     
NETRIN1 acoustic_radiation -0.002 0.010 -0.187 0.852 
NETRIN1 anterior_thalamic_radiation 0.020 0.011 1.854 0.064 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.017 0.011 1.586 0.113 
NETRIN1 
parahippocampal_part_of_cingulum -0.009 0.011 -0.813 0.416 
NETRIN1 corticospinal_tract 0.008 0.011 0.694 0.488 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.025 0.011 2.193 0.028 
NETRIN1 
inferior_longitudinal_fasciculus 0.025 0.011 2.221 0.026 
NETRIN1 medial_lemniscus 0.004 0.011 0.338 0.736 
NETRIN1 posterior_thalamic_radiation 0.020 0.011 1.878 0.060 
NETRIN1 
superior_longitudinal_fasciculus 0.030 0.011 2.603 0.009 
NETRIN1 superior_thalamic_radiation 0.020 0.010 2.051 0.040 
NETRIN1 uncinate_fasciculus 0.015 0.010 1.421 0.155 
NETRIN1 forceps_major 0.014 0.012 1.181 0.237 
NETRIN1 forceps_minor 0.014 0.012 1.202 0.229 
NETRIN1 middle_cerebellar_peduncle 0.009 0.012 0.759 0.448 
Genomic acoustic_radiation -0.002 0.010 -0.177 0.860 
Genomic anterior_thalamic_radiation 0.013 0.011 1.216 0.224 
Genomic 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.359 0.174 
Genomic 
parahippocampal_part_of_cingulum 0.018 0.011 1.678 0.093 
Genomic corticospinal_tract 0.002 0.011 0.205 0.838 
Genomic 
inferior_fronto_occipital_fasciculus 0.014 0.011 1.238 0.216 
Genomic 
inferior_longitudinal_fasciculus 0.006 0.011 0.495 0.621 
Genomic medial_lemniscus -0.002 0.011 -0.204 0.839 
Genomic posterior_thalamic_radiation -0.010 0.011 -0.972 0.331 
Genomic 
superior_longitudinal_fasciculus 0.008 0.011 0.667 0.505 
Genomic superior_thalamic_radiation 0.006 0.010 0.582 0.561 
Genomic uncinate_fasciculus 0.010 0.010 0.960 0.337 
Genomic forceps_major 0.014 0.012 1.202 0.230 
Genomic forceps_minor 0.016 0.012 1.425 0.154 
Genomic middle_cerebellar_peduncle 0.011 0.012 0.870 0.384 
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 Value Std. Error t-value p-value 
PGRS THRESHOLD: 1     
NETRIN1 acoustic_radiation -0.003 0.010 -0.333 0.739 
NETRIN1 anterior_thalamic_radiation 0.022 0.011 2.070 0.039 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.018 0.011 1.698 0.089 
NETRIN1 
parahippocampal_part_of_cingulum -0.006 0.011 -0.608 0.543 
NETRIN1 corticospinal_tract 0.009 0.011 0.789 0.430 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.024 0.011 2.176 0.030 
NETRIN1 
inferior_longitudinal_fasciculus 0.023 0.011 2.018 0.044 
NETRIN1 medial_lemniscus 0.004 0.011 0.355 0.723 
NETRIN1 posterior_thalamic_radiation 0.020 0.011 1.875 0.061 
NETRIN1 
superior_longitudinal_fasciculus 0.029 0.011 2.576 0.010 
NETRIN1 superior_thalamic_radiation 0.021 0.010 2.132 0.033 
NETRIN1 uncinate_fasciculus 0.016 0.010 1.562 0.118 
NETRIN1 forceps_major 0.013 0.012 1.067 0.286 
NETRIN1 forceps_minor 0.016 0.012 1.403 0.161 
NETRIN1 middle_cerebellar_peduncle 0.008 0.012 0.664 0.507 
Genomic acoustic_radiation -0.003 0.010 -0.318 0.750 
Genomic anterior_thalamic_radiation 0.013 0.011 1.202 0.229 
Genomic 
cingulate_gyrus_part_of_cingulum 0.014 0.011 1.292 0.196 
Genomic 
parahippocampal_part_of_cingulum 0.019 0.011 1.780 0.075 
Genomic corticospinal_tract 0.003 0.011 0.258 0.796 
Genomic 
inferior_fronto_occipital_fasciculus 0.013 0.011 1.167 0.243 
Genomic 
inferior_longitudinal_fasciculus 0.005 0.011 0.471 0.638 
Genomic medial_lemniscus -0.004 0.011 -0.396 0.692 
Genomic posterior_thalamic_radiation -0.013 0.011 -1.172 0.241 
Genomic 
superior_longitudinal_fasciculus 0.006 0.011 0.549 0.583 
Genomic superior_thalamic_radiation 0.005 0.010 0.464 0.643 
Genomic uncinate_fasciculus 0.010 0.010 0.983 0.326 
Genomic forceps_major 0.015 0.012 1.282 0.200 
Genomic forceps_minor 0.012 0.012 1.044 0.296 
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Table S19. The effect of pruned NETRIN1- and Genomic-PRS at thresholds 0.01, 0.05, 0.1, 
0.5 and 1 on tract categories (MD) (N = 6,390). 
 
 Value Std. Error t-value p-value 
PGRS THRESHOLD: 0.01     
NETRIN1 gMD 0.011 0.012 0.998 0.318 
NETRIN1 Association fibres 0.009 0.012 0.737 0.461 
NETRIN1 Thalamic radiations 0.010 0.011 0.896 0.370 
NETRIN1 Projection fibres 0.005 0.012 0.429 0.668 
Genomic gMD 0.018 0.011 1.546 0.122 
Genomic Association fibres 0.020 0.012 1.690 0.091 
Genomic Thalamic radiations 0.011 0.011 1.041 0.298 
Genomic Projection fibres 0.015 0.012 1.205 0.228 
     
PGRS THRESHOLD: 0.05     
NETRIN1 gMD 0.010 0.011 0.844 0.399 
NETRIN1 Association fibres 0.012 0.012 0.995 0.320 
NETRIN1 Thalamic radiations 0.010 0.011 0.916 0.360 
NETRIN1 Projection fibres -0.003 0.012 -0.268 0.789 
Genomic gMD 0.021 0.011 1.798 0.072 
Genomic Association fibres 0.022 0.012 1.913 0.056 
Genomic Thalamic radiations 0.012 0.011 1.091 0.276 
Genomic Projection fibres 0.019 0.012 1.595 0.111 
     
PGRS THRESHOLD: 0.1     
NETRIN1 gMD 0.015 0.011 1.327 0.184 
NETRIN1 Association fibres 0.011 0.012 0.970 0.332 
NETRIN1 Thalamic radiations 0.017 0.011 1.583 0.114 
NETRIN1 Projection fibres 0.010 0.012 0.796 0.426 
Genomic gMD 0.012 0.011 1.064 0.287 
Genomic Association fibres 0.018 0.012 1.539 0.124 
Genomic Thalamic radiations 0.001 0.011 0.120 0.904 
Genomic Projection fibres 0.012 0.012 1.010 0.312 
     
PGRS THRESHOLD: 0.5     
NETRIN1 gMD 0.020 0.011 1.783 0.075 
NETRIN1 Association fibres 0.015 0.012 1.328 0.184 
NETRIN1 Thalamic radiations 0.023 0.011 2.169 0.030 
NETRIN1 Projection fibres 0.014 0.012 1.171 0.242 
Genomic gMD 0.012 0.011 1.045 0.296 
Genomic Association fibres 0.018 0.012 1.526 0.127 
Genomic Thalamic radiations 0.001 0.011 0.050 0.960 
Genomic Projection fibres 0.014 0.012 1.174 0.240 
     
PGRS THRESHOLD: 1     
NETRIN1 gMD 0.021 0.011 1.829 0.068 
NETRIN1 Association fibres 0.016 0.012 1.412 0.158 
NETRIN1 Thalamic radiations 0.024 0.011 2.263 0.024 
NETRIN1 Projection fibres 0.013 0.012 1.060 0.289 
Genomic gMD 0.011 0.011 0.979 0.328 
Genomic Association fibres 0.018 0.012 1.533 0.125 
Genomic Thalamic radiations -0.001 0.011 -0.091 0.928 
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Table S20. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on 
individual white matter tracts (MD) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 acoustic_radiation -0.002 0.011 -0.223 0.824 
NETRIN1 anterior_thalamic_radiation 0.015 0.011 1.434 0.151 
NETRIN1 
cingulate_gyrus_part_of_cingulum 0.013 0.011 1.153 0.249 
NETRIN1 
parahippocampal_part_of_cingulum -0.008 0.011 -0.762 0.446 
NETRIN1 corticospinal_tract 0.004 0.012 0.341 0.733 
NETRIN1 
inferior_fronto_occipital_fasciculus 0.020 0.011 1.764 0.078 
NETRIN1 
inferior_longitudinal_fasciculus 0.020 0.011 1.779 0.075 
NETRIN1 medial_lemniscus 0.001 0.011 0.059 0.953 
NETRIN1 posterior_thalamic_radiation 0.017 0.011 1.588 0.112 
NETRIN1 
superior_longitudinal_fasciculus 0.023 0.011 2.036 0.042 
NETRIN1 superior_thalamic_radiation 0.015 0.010 1.456 0.145 
NETRIN1 uncinate_fasciculus 0.012 0.011 1.102 0.271 
NETRIN1 forceps_major 0.014 0.012 1.146 0.252 
NETRIN1 forceps_minor 0.011 0.012 0.949 0.342 
NETRIN1 middle_cerebellar_peduncle 0.007 0.012 0.573 0.567 
Genomic acoustic_radiation -0.009 0.011 -0.817 0.414 
Genomic anterior_thalamic_radiation 0.003 0.011 0.261 0.794 
Genomic 
cingulate_gyrus_part_of_cingulum 0.003 0.011 0.234 0.815 
Genomic 
parahippocampal_part_of_cingulum 0.010 0.011 0.980 0.327 
Genomic corticospinal_tract -0.008 0.012 -0.656 0.512 
Genomic 
inferior_fronto_occipital_fasciculus 0.002 0.011 0.164 0.870 
Genomic 
inferior_longitudinal_fasciculus -0.005 0.011 -0.427 0.669 
Genomic medial_lemniscus -0.009 0.011 -0.790 0.430 
Genomic posterior_thalamic_radiation -0.018 0.011 -1.651 0.099 
Genomic 
superior_longitudinal_fasciculus -0.002 0.012 -0.187 0.851 
Genomic superior_thalamic_radiation -0.004 0.011 -0.335 0.738 
Genomic uncinate_fasciculus 0.000 0.011 -0.035 0.972 
Genomic forceps_major 0.005 0.012 0.440 0.660 
Genomic forceps_minor 0.004 0.012 0.352 0.725 




Table S21. The effect of unpruned NETRIN1- and Genomic-PRS at threshold 0.5 on tract 
categories (MD) (N = 6,420). 
 
PGRS THRESHOLD: 0.5 Value Std. Error t-value p-value 
NETRIN1 gMD 2.53E-06 1.42E-06 1.78E+00 7.47E-02 
NETRIN1 Association fibres 1.43E-06 1.08E-06 1.33E+00 1.84E-01 
NETRIN1 Thalamic radiations 1.71E-06 7.87E-07 2.17E+00 3.01E-02 
NETRIN1 Projection fibres 9.36E-07 8.00E-07 1.17E+00 2.42E-01 
Genomic gMD 1.50E-06 1.43E-06 1.04E+00 2.96E-01 
Genomic Association fibres 1.66E-06 1.09E-06 1.53E+00 1.27E-01 
Genomic Thalamic radiations 3.99E-08 7.93E-07 5.02E-02 9.60E-01 
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Results depicted in tables S6 – S21 indicate secondary analyses which complement our 
primary analyses. These consist firstly of the effect unpruned NETRIN1- and genomic-PRS 
on FA and MD values, conducted on both the full dataset (N = 6,420) and the dataset with 
excluded outliers (N = 6,401 and 6,390 for FA and MD, respectively). Secondly, we also 
investigated the effect of pruned NETRIN1- and genomic-PRS on FA and MD values, again 
conducted on both the full dataset and dataset with excluded outliers. The analyses consist of 
PRS at all five p-value thresholds (0.01, 0.05, 0.1, 0.5 and 1). A similar pattern is observed 
for significance in white matter tracts associated with both PRS lists across PRS thresholds 
within the dataset with outliers removed. Some tracts remain significant within the full 
sample dataset as compared to the sample with outliers removed at PRS threshold 0.5, 
however there is a trend towards more significant results when outliers are removed. Please 
refer to tables S8-S9, S12-S13, S16-S17 and S20-S21 for an account of results at PRS 
threshold 0.5 within the full dataset, which are directly comparable to the primary results 
depicted in the manuscript (PRS threshold 0.5 with outliers removed). 
 
White matter tracts significantly associated with both NETRIN1-PRS and genomic-PRS 
Fractional anisotropy 
Tract categories 
Significantly lower FA values in association fibres were found for both NETRIN1-PRS (β =  
-0.032, pcorrected = 0.023) and genomic-PRS (β = -0.033, pcorrected = 0.011). 
Mean diffusivity 
Global measures 
Significantly higher gMD was associated with both NETRIN1-PRS (β = 0.027, pcorrected = 
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Individual white matter tracts 
Significantly higher MD in the inferior fronto-occipital fasciculus was found for both 
NETRIN1-PRS (β = 0.027, pcorrected = 0.046)  and genomic-PRS (β = 0.031, pcorrected = 0.018). 
 
Data analysis code – example  
 
############## NETRIN1 & Genomic-PRS analysis ################## 
 





# Read in PRS lists and imaging data 
 
# OUTLIER EXCLUSION - FA (apply PCA on all regions in original dataset) 
 





pca_data = targetdata[,c(grep(IM.measure,colnames(targetdata)))] 
pca_fit <- princomp((-1*pca_data), scores = TRUE)  





# Read in dataset containing unrelated British individual to exclude related individuals 
 
#Merge NETRIN1 PGRS with target imaging data 
 
#UKB_merge1 = merge(UKB_subset,NETRIN1_pgrs,by="f.eid",all.x=TRUE) 
 
# Read in: MRI position covariates, descriptive statistics (age, sex, etc.), principal 
components, genotype array 
 
# Merge imaging with all covariates that were read in above 
 
# Example: Merge baseline with UKB_merge1 (containing PRS and imaging data) 
 
baseline = data.frame(baseline[,1:2]) 
colnames(baseline)[2] <-"sex" 
UKB_merge4 = merge(UKB_merge1,baseline,by="f.eid",all.x=TRUE) 
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# SCALE DEPENDENT AND INDEPENDENT VARIABLES BEFORE PUTTING THEM 
IN LONG FORMAT 
 
UKB_final[,c(2:28,31:40)] <- scale(UKB_final[,c(2:28,31:40)]) #2:28 are the white matter 
tracts, while 31:40 are the NETRIN1 PGRS 
#######   Prep long format data   ###### output: data_long 
 
# settings; change colnames of non-imaging data and imaging data according to the dataset 
you are using - with or without outliers 
 
targetdata = UKB_final 
cols_nonimg = colnames(targetdata)[29:ncol(targetdata)]  # colnames of non-imaging data 
dat_colnames = colnames(targetdata)[2:28]  # colnames of imaging data 





dat_long <- long_format(targetdata,cols_nonimg,cols_img,measures) 
 
# set the data in regression format 
# the sequence of data from left to right: 
# f.eid || factors || dependent variables || covariates 
# Order the column numbers below according to the variables above: f.eid first, then factors 
(PGRS lists), 
# then dependent variables (DTI variables in this case), and then covariates (age, sex, 15 PCs, 
genotype array, hemisphere) 
# (factors=the last input of an equation) 
 
targetdata_long = dat_long[,c(1,16:25,2:13,15,26,28:30,27,31:34,35:49,50)]     # long-format 
data  
#This includes: f.eid, 10 PGRS lists, 12 bilateral DTI measures, MRI age calculated,  
#sex, pos_covar, array, PCs & hemi 
targetdata_long = targetdata_long[complete.cases(targetdata_long),] #complete cases for all 
variables 
 
targetdata_short = UKB_final[,c(1,31:40,2:28,30,41,43:45,42,46:49,50:64)]    # short-format 
data for outliers excluded 
targetdata_short = targetdata_short[complete.cases(targetdata_short),] #complete cases for all 
variables 
 
# REGRESSION ANALYSIS 
# FA - 0.5; use targetdata_long and targetdata_short (depending on white matter tract) for 
analysis 
 
WM_list <- colnames(targetdata_long)[2:13] # select all WM tracts to run regression 
no_WM_list <- length(WM_list) # assign length of columns 
 
# create a named list to hold the fitted models 
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names(fitlist) <- WM_list 
 
for(i in WM_list){  
  # create temporary data matrix and model formula 
  tmp <- targetdata_long[, c(i,"sex","MRI_age.calculated","pc1","pc2","pc3","pc4", 
                             "pc5","pc6","pc7","pc8","pc9","pc10","pc11","pc12","pc13","pc14","pc15
","genotyping.array", 
                             "pos.x", "pos.y", 
"pos.z","NETRIN1_WG_pT_0.5","NETRIN1_pathway_pT_0.5","f.eid")] 
  fml <- as.formula( paste(i, "~",  
                           paste(c("sex","I(MRI_age.calculated^2)","MRI_age.calculated","pc1","pc2",
"pc3","pc4","pc5","pc6","pc7","pc8","pc9", 
                                   "pc10","pc11","pc12","pc13","pc14","pc15","genotyping.array","pos.x
", "pos.y",  
                                   "pos.z",”hemi”,"NETRIN1_WG_pT_0.5","NETRIN1_pathway_pT_0.
5"), collapse="+") ) ) 
  # assign fit to list by name 
  fitlist[[i]] <- lme(fml, random=~1|f.eid,na.action=na.exclude,control=lmeControl(opt = 
"optim"), data=tmp)  
} 
 
FA_0.5 <- lapply(fitlist, summary) 
 
# FDR correction – conducted separately for NETRIN1 and Genomic-PRS p-values 
 
# INDIVIDUAL WHITE MATTER TRACTS 
 
FA_Pvalues_categories_ind_tracts$p.corrected_fdr = 
  p.adjust(FA_Pvalues_categories_ind_tracts$V2, 
           method = "fdr") 
 
write.table(FA_Pvalues_categories_ind_tracts, "FA_ind_tract_FDR_Pvalue",sep="\t")  
 
# TRACT CATEGORIES 
 
FA_Pvalues_categories_gFA$p.corrected_fdr = 
  p.adjust(FA_Pvalues_categories_gFA$V2, 
           method = "fdr") 
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